臺灣核心實作指引(TW Core IG)
0.3.1 - Trial Use
臺灣核心實作指引(TW Core IG)
0.3.1 - Trial Use
This page is part of the 臺灣核心實作指引(TW Core IG) (v0.3.1: Releases) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
| Official URL: https://twcore.mohw.gov.tw/ig/twcore/ValueSet/medcation-atc-tw | Version: 2022-10-24 | |||
| Active as of 2014-09-19 | Computable Name: TWMedcationATC | |||
臺灣食藥署藥品藥理治療分類ATC碼值集。 資料提供單位：衛生福利部食品藥物管理署。
References
Generated Narrative: ValueSet medcation-atc-tw
http://www.whocc.no/atc| Code | Display |
| A01AB14 | benzoxonium chloride |
| A02AA05 | magnesium silicate |
| A02AD01 | ordinary salt combinations |
| A02AG | Antacids with antispasmodics |
| A02BD05 | omeprazole, amoxicillin and clarithromycin |
| A02BD10 | lansoprazole, amoxicillin and levofloxacin |
| A02BX02 | sucralfate |
| A02BX03 | pirenzepine |
| A03AD01 | papaverine |
| A03AX | Other drugs for functional gastrointestinal disorders |
| A03AX58 | alverine, combinations |
| A03CB31 | hyoscyamine and psycholeptics |
| A04AD01 | scopolamine |
| A05AA03 | cholic acid |
| A05AX02 | hymecromone |
| A05BA04 | citiolone |
| A06AB20 | contact laxatives in combination |
| A06AB52 | bisacodyl, combinations |
| A06AD10 | mineral salts in combination |
| A06AG10 | docusate sodium, incl. combinations |
| A07AA08 | kanamycin |
| A07AC01 | miconazole |
| A07DA02 | opium |
| A07E | INTESTINAL ANTIINFLAMMATORY AGENTS |
| A07EA03 | prednisone |
| A07EA07 | beclometasone |
| A07EC01 | sulfasalazine |
| A07FA51 | lactic acid producing organisms, combinations |
| A09AB02 | betaine hydrochloride |
| A10AB04 | insulin lispro |
| A10AB05 | insulin aspart |
| A10BB08 | gliquidone |
| A10BD11 | metformin and linagliptin |
| A10BD24 | sitagliptin and ertugliflozin |
| A10BK03 | empagliflozin |
| A11AA | Multivitamins with minerals |
| A11CC55 | colecalciferol, combinations |
| A11DA03 | benfotiamine |
| A11DB | Vitamin B1 in combination with vitamin B6 and/or vitamin B12 |
| A11G | ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS |
| A11JA | Combinations of vitamins |
| A11JB | Vitamins with minerals |
| A12AA09 | calcium citrate lysine complex |
| A12BA02 | potassium citrate |
| A12BA04 | potassium hydrogencarbonate |
| A12BA51 | potassium chloride, combinations |
| A12CB | Zinc |
| A13A | TONICS |
| A14AA02 | stanozolol |
| A16AA | Amino acids and derivatives |
| A16AB02 | imiglucerase |
| A16AB04 | agalsidase beta |
| A16AB09 | idursulfase |
| A16AB17 | cerliponase alfa |
| B01AB04 | dalteparin |
| B01AC16 | eptifibatide |
| B01AD02 | alteplase |
| B01AD04 | urokinase |
| B02AB01 | aprotinin |
| B02B | VITAMIN K AND OTHER HEMOSTATICS |
| B02BD02 | coagulation factor VIII |
| B02BX01 | etamsylate |
| B03AA12 | ferrous sodium citrate |
| B03BA | Vitamin B12 (cyanocobalamin and analogues) |
| B05BA02 | fat emulsions |
| B05BB01 | electrolytes |
| B05BB04 | electrolytes in combination with other drugs |
| B05BC01 | mannitol |
| B05CA03 | nitrofural |
| B05CX03 | glycine |
| B05D | PERITONEAL DIALYTICS |
| B05DA | Isotonic solutions |
| B05X | I.V. SOLUTION ADDITIVES |
| B05XA08 | sodium acetate |
| B05XA09 | sodium phosphate |
| B05XA17 | potassium acetate |
| B05XX02 | trometamol |
| B05Z | HEMODIALYTICS AND HEMOFILTRATES |
| B06A | OTHER HEMATOLOGICAL AGENTS |
| B06AC01 | c1-inhibitor, plasma derived |
| C01AA04 | digitoxin |
| C01BC03 | propafenone |
| C01CA01 | etilefrine |
| C01CA17 | midodrine |
| C01CE02 | milrinone |
| C01DA05 | pentaerithrityl tetranitrate |
| C01DA08 | isosorbide dinitrate |
| C01EB10 | adenosine |
| C01EB17 | ivabradine |
| C02AB | Methyldopa |
| C02CC02 | guanethidine |
| C02DA01 | diazoxide |
| C02KX05 | riociguat |
| C02LE01 | prazosin and diuretics |
| C02LG02 | hydralazine and diuretics |
| C03BA11 | indapamide |
| C03CA01 | furosemide |
| C03CB01 | furosemide and potassium |
| C03DA04 | eplerenone |
| C03DB01 | amiloride |
| C03EA01 | hydrochlorothiazide and potassium-sparing agents |
| C03EB01 | furosemide and potassium-sparing agents |
| C04AA02 | buphenine |
| C04AE | Ergot alkaloids |
| A01AA01 | sodium fluoride |
| A01AB09 | miconazole |
| A01AB11 | various |
| A01AB22 | doxycycline |
| A01AC54 | prednisolone, combinations |
| A02AB | Aluminium compounds |
| A02AC | Calcium compounds |
| A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds |
| A02AF01 | magaldrate and antiflatulents |
| A02BC01 | omeprazole |
| A02BC53 | lansoprazole, combinations |
| A03AB19 | timepidium bromide |
| A03AX04 | pinaverium |
| A03DB04 | butylscopolamine and analgesics |
| A04AA03 | tropisetron |
| A05AX | Other drugs for bile therapy |
| A05B | LIVER THERAPY, LIPOTROPICS |
| A05BA03 | silymarin |
| A05C | DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION |
| A06AB | Contact laxatives |
| A06AB04 | phenolphthalein |
| A06AD02 | magnesium oxide |
| A06AD13 | sodium sulfate |
| A06AG01 | sodium phosphate |
| A06AG20 | combinations |
| A06AX05 | prucalopride |
| A07EA01 | prednisolone |
| A07FA | Antidiarrheal microorganisms |
| A08AB01 | orlistat |
| A09A | DIGESTIVES, INCL. ENZYMES |
| A09AB03 | hydrochloric acid |
| A09AC | Enzyme and acid preparations, combinations |
| A10A | INSULINS AND ANALOGUES |
| A10AB03 | insulin (pork) |
| A10AE05 | insulin detemir |
| A10BB09 | gliclazide |
| A10BD03 | metformin and rosiglitazone |
| A10BD19 | linagliptin and empagliflozin |
| A10BF02 | miglitol |
| A10BG02 | rosiglitazone |
| A10BX08 | mitiglinide |
| A11A | MULTIVITAMINS, COMBINATIONS |
| A11AA02 | multivitamins and calcium |
| A11BA | Multivitamins, plain |
| A11CC | Vitamin D and analogues |
| A11CC01 | ergocalciferol |
| A11CC03 | alfacalcidol |
| A11DA01 | thiamine (vit B1) |
| A11GA | Ascorbic acid (vitamin C), plain |
| A11H | OTHER PLAIN VITAMIN PREPARATIONS |
| A11HA | Other plain vitamin preparations |
| A11HA07 | inositol |
| A11JC | Vitamins, other combinations |
| A12 | MINERAL SUPPLEMENTS |
| A12AA08 | calcium glycerylphosphate |
| A12AA20 | calcium (different salts in combination) |
| A12CA01 | sodium chloride |
| A12CB02 | zinc gluconate |
| A12CC01 | magnesium chloride |
| B01AC05 | ticlopidine |
| B01AC21 | treprostinil |
| B02BA02 | menadione |
| B02BB | Fibrinogen |
| B02BX | Other systemic hemostatics |
| B02BX04 | romiplostim |
| B03AB02 | saccharated iron oxide |
| B03AD | Iron in combination with folic acid |
| B03BA05 | mecobalamin |
| B03BB51 | folic acid, combinations |
| B05BA10 | combinations |
| B05C | IRRIGATING SOLUTIONS |
| B05CA04 | sulfamethizole |
| B05XA31 | electrolytes in combination with other drugs |
| B05XB03 | lysine |
| B05ZB | Hemofiltrates |
| B06AB | Heme products |
| C01EA | Prostaglandins |
| C02AB01 | methyldopa (levorotatory) |
| C02KX01 | bosentan |
| C02LA01 | reserpine and diuretics |
| C02LA51 | reserpine and diuretics, combinations with other drugs |
| C03AA04 | chlorothiazide |
| C04AE01 | ergoloid mesylates |
| C04AX11 | bencyclane |
| C05A | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| C05AA10 | fluocinolone acetonide |
| C05AD03 | benzocaine |
| C05AX01 | aluminium preparations |
| C05CX | Other capillary stabilizing agents |
| C07AA01 | alprenolol |
| C07AA15 | carteolol |
| C08CA09 | lacidipine |
| C08CA15 | benidipine |
| C09CA01 | losartan |
| C09CA04 | irbesartan |
| C09DA | Angiotensin II receptor blockers (ARBs) and diuretics |
| C09DB02 | olmesartan medoxomil and amlodipine |
| C09DB09 | fimasartan and amlodipine |
| C09DX04 | valsartan and sacubitril |
| C09DX07 | irbesartan, amlodipine and hydrochlorothiazide |
| C09XA52 | aliskiren and hydrochlorothiazide |
| A02AA01 | magnesium carbonate |
| A02AB03 | aluminium phosphate |
| A02AB07 | aluminium glycinate |
| A02AD03 | almagate |
| A02BA01 | cimetidine |
| A02BA02 | ranitidine |
| A02BA06 | roxatidine |
| A02BC04 | rabeprazole |
| A02BD01 | omeprazole, amoxicillin and metronidazole |
| A02BD09 | lansoprazole, clarithromycin and tinidazole |
| A02BD13 | rabeprazole, amoxicillin and metronidazole |
| A02BX04 | methiosulfonium chloride |
| A03AA30 | piperidolate |
| A03AB | Synthetic anticholinergics, quaternary ammonium compounds |
| A03AB05 | propantheline |
| A03AB17 | tiemonium iodide |
| A03AB21 | fenpiverinium |
| A03AD | Papaverine and derivatives |
| A03BA04 | belladonna total alkaloids |
| A03FA04 | bromopride |
| A04AD02 | cerium oxalate |
| A06A | DRUGS FOR CONSTIPATION |
| A06AC08 | polycarbophil calcium |
| A06AD | Osmotically acting laxatives |
| A06AG07 | sorbitol |
| A07AA09 | vancomycin |
| A07BC04 | attapulgite |
| A07EA02 | hydrocortisone |
| A07X | OTHER ANTIDIARRHEALS |
| A07XA51 | albumin tannate, combinations |
| A09AA01 | diastase |
| A09AB04 | citric acid |
| A10AE01 | insulin (human) |
| A10BB | Sulfonylureas |
| A10BB12 | glimepiride |
| A10BD02 | metformin and sulfonylureas |
| A10BD18 | metformin and gemigliptin |
| A10BH04 | alogliptin |
| A10BK01 | dapagliflozin |
| A10BX03 | nateglinide |
| A11EC | Vitamin B-complex with minerals |
| A11EX | Vitamin B-complex, other combinations |
| A11HA31 | calcium pantothenate |
| A11J | OTHER VITAMIN PRODUCTS, COMBINATIONS |
| A12CC03 | magnesium gluconate |
| A16AB03 | agalsidase alfa |
| A16AX05 | zinc acetate |
| A16AX06 | miglustat |
| B01AB02 | antithrombin III |
| B01AD12 | protein C |
| B02AA02 | tranexamic acid |
| B02BB01 | fibrinogen, human |
| B02BC01 | absorbable gelatin sponge |
| B02BC09 | epinephrine |
| B02BD04 | coagulation factor IX |
| B02BD10 | von Willebrand factor |
| B03AB07 | chondroitin sulfate-iron complex |
| B03BA02 | cyanocobalamin tannin complex |
| B03XA03 | methoxy polyethylene glycol-epoetin beta |
| B05AA01 | albumin |
| B05AA02 | other plasma protein fractions |
| B05CX04 | mannitol |
| B05XA01 | potassium chloride |
| B05XA02 | sodium bicarbonate |
| B05XA11 | magnesium chloride |
| B06AA55 | streptokinase, combinations |
| C01AA05 | digoxin |
| C01BB01 | lidocaine |
| C01BB02 | mexiletine |
| C01BD | Antiarrhythmics, class III |
| C01CX08 | levosimendan |
| C01DA02 | glyceryl trinitrate |
| C01DX16 | nicorandil |
| C01EB16 | ibuprofen |
| C02KX02 | ambrisentan |
| C02KX04 | macitentan |
| C02LC01 | clonidine and diuretics |
| C02LG51 | dihydralazine and diuretics, combinations with other drugs |
| C03AA | Thiazides, plain |
| C03BA02 | quinethazone |
| C03CB02 | bumetanide and potassium |
| C03DB02 | triamterene |
| C04AE54 | dihydroergocristine, combinations |
| C04AX10 | moxisylyte |
| C05AD | Local anesthetics |
| C05BA01 | organo-heparinoid |
| C05BA03 | heparin |
| C05CA53 | diosmin, combinations |
| C07AA05 | propranolol |
| C07CB03 | atenolol and other diuretics |
| C07CB53 | atenolol and other diuretics, combinations |
| C07DB01 | atenolol, thiazides and other diuretics |
| C07FB13 | metoprolol and amlodipine |
| C08CA08 | nitrendipine |
| C08GA01 | nifedipine and diuretics |
| C09AA07 | benazepril |
| C09BX01 | perindopril, amlodipine and indapamide |
| C09CA07 | telmisartan |
| C09CA09 | azilsartan medoxomil |
| C09DA08 | olmesartan medoxomil and diuretics |
| C09DB07 | candesartan and amlodipine |
| A01AA51 | sodium fluoride, combinations |
| A01AB06 | domiphen |
| A02AA | Magnesium compounds |
| A02AA02 | magnesium oxide |
| A02AB10 | combinations |
| A02AC01 | calcium carbonate |
| A02BA03 | famotidine |
| A02BA53 | famotidine, combinations |
| A02BB01 | misoprostol |
| A02BC03 | lansoprazole |
| A02BC05 | esomeprazole |
| A02BD06 | esomeprazole, amoxicillin and clarithromycin |
| A02BD08 | bismuth subcitrate, tetracycline and metronidazole |
| A02BD12 | rabeprazole, amoxicillin and clarithromycin |
| A02BX06 | proglumide |
| A03AA05 | trimebutine |
| A03AB02 | glycopyrronium bromide |
| A03AB12 | mepenzolate |
| A03BA | Belladonna alkaloids, tertiary amines |
| A03BA01 | atropine |
| A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds |
| A03BB01 | butylscopolamine |
| A03C | ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS |
| A04AA05 | palonosetron |
| A04AD | Other antiemetics |
| A05AA | Bile acids and derivatives |
| A05AX03 | cyclobutyrol |
| A05BA | Liver therapy |
| A05BA08 | glycyrrhizic acid |
| A06AB06 | senna glycosides |
| A06AC01 | ispaghula (psylla seeds) |
| A06AD01 | magnesium carbonate |
| A06AD12 | lactitol |
| A06AD18 | sorbitol |
| A06AG02 | bisacodyl |
| A07AA10 | colistin |
| A07AX | Other intestinal antiinfectives |
| A07BA | Charcoal preparations |
| A07BC02 | kaolin |
| A07XA01 | albumin tannate |
| A07XA04 | racecadotril |
| A10AB06 | insulin glulisine |
| A10AD04 | insulin lispro |
| A10AD30 | combinations |
| A10BB02 | chlorpropamide |
| A10BB07 | glipizide |
| A10BD05 | metformin and pioglitazone |
| A10BD06 | glimepiride and pioglitazone |
| A10BD12 | pioglitazone and sitagliptin |
| A10BD14 | metformin and repaglinide |
| A10BJ05 | dulaglutide |
| A11AA03 | multivitamins and other minerals, incl. combinations |
| A11CB | Vitamin A and D in combination |
| A12AA03 | calcium gluconate |
| A12CA | Sodium |
| A12CC | Magnesium |
| A12CC10 | magnesium oxide |
| A12CX | Other mineral products |
| A14AA03 | metandienone |
| A16AA01 | levocarnitine |
| A16AB05 | laronidase |
| A16AX01 | thioctic acid |
| A16AX12 | trientine |
| B01AA03 | warfarin |
| B01AB | Heparin group |
| B01AB01 | heparin |
| B01AC07 | dipyridamole |
| B01AF01 | rivaroxaban |
| B02BD | Blood coagulation factors |
| B02BD03 | factor VIII inhibitor bypassing activity |
| B03AB01 | ferric sodium citrate |
| B03AD03 | ferrous sulfate |
| B03BA51 | cyanocobalamin, combinations |
| B03BA53 | hydroxocobalamin, combinations |
| B03XA | Other antianemic preparations |
| B05BA03 | carbohydrates |
| B05BB02 | electrolytes with carbohydrates |
| B05CB03 | magnesium citrate |
| B05CB04 | sodium bicarbonate |
| B05CX01 | glucose |
| B05DB | Hypertonic solutions |
| B05XA07 | calcium chloride |
| B05XA30 | combinations of electrolytes |
| B05XB | Amino acids |
| B06AA | Enzymes |
| B06AC02 | icatibant |
| C01BA03 | disopyramide |
| C01CA06 | phenylephrine |
| C01CA07 | dobutamine |
| C01CA26 | ephedrine |
| C01DX22 | vericiguat |
| C01EB18 | ranolazine |
| C02AC01 | clonidine |
| C02DB02 | hydralazine |
| C02DD01 | nitroprusside |
| C02KX52 | ambrisentan and tadalafil |
| C03AA05 | polythiazide |
| C03AA06 | trichlormethiazide |
| C03BA05 | mefruside |
| C03CA02 | bumetanide |
| C03CA04 | torasemide |
| C04AC03 | inositol nicotinate |
| C04AE02 | nicergoline |
| C05AA01 | hydrocortisone |
| C05AD05 | procaine |
| C05BA | Heparins or heparinoids for topical use |
| C05CA03 | diosmin |
| C05CX03 | Hippocastani semen |
| C07AA06 | timolol |
| A01AA | Caries prophylactic agents |
| A01AB13 | tetracycline |
| A01AB21 | chlortetracycline |
| A01AB23 | minocycline |
| A01AC | Corticosteroids for local oral treatment |
| A01AC03 | hydrocortisone |
| A01AD01 | epinephrine |
| A01AD05 | acetylsalicylic acid |
| A02AA03 | magnesium peroxide |
| A02AB02 | algeldrate |
| A02AD05 | almasilate |
| A02BA51 | cimetidine, combinations |
| A02BD04 | pantoprazole, amoxicillin and clarithromycin |
| A02BD14 | vonoprazan, amoxicillin and clarithromycin |
| A03AA01 | oxyphencyclimine |
| A03AA03 | camylofin |
| A03AA04 | mebeverine |
| A03AB18 | prifinium bromide |
| A03B | BELLADONNA AND DERIVATIVES, PLAIN |
| A03CA02 | clidinium and psycholeptics |
| A03CB02 | belladonna total alkaloids and psycholeptics |
| A03CB04 | homatropine methylbromide and psycholeptics |
| A03ED | Antispasmodics in combination with other drugs |
| A03FA | Propulsives |
| A03FA01 | metoclopramide |
| A03FA03 | domperidone |
| A05 | BILE AND LIVER THERAPY |
| A05AA02 | ursodeoxycholic acid |
| A06AB08 | sodium picosulfate |
| A06AB30 | contact laxatives in combination with belladonna alkaloids |
| A06AB56 | senna glycosides, combinations |
| A06AC03 | sterculia |
| A06AD04 | magnesium sulfate |
| A06AD11 | lactulose |
| A06AD15 | macrogol |
| A06AD16 | mannitol |
| A06AH05 | naldemedine |
| A06AX | Other drugs for constipation |
| A07AA01 | neomycin |
| A07AA51 | neomycin, combinations |
| A07BC05 | diosmectite |
| A07DA03 | loperamide |
| A07EB01 | cromoglicic acid |
| A08AA10 | sibutramine |
| A09AC02 | multienzymes and acid preparations |
| A10AC03 | insulin (pork) |
| A10AE04 | insulin glargine |
| A10BB01 | glibenclamide |
| A10BD07 | metformin and sitagliptin |
| A10BD22 | metformin and evogliptin |
| A10BH02 | vildagliptin |
| A10BH05 | linagliptin |
| A10BJ01 | exenatide |
| A10BX01 | guar gum |
| A10BX02 | repaglinide |
| A11AB | Multivitamins, other combinations |
| A11C | VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO |
| A11CA02 | betacarotene |
| A11EB | Vitamin B-complex with vitamin C |
| A11HA01 | nicotinamide |
| A11HA03 | tocopherol (vit E) |
| A11HA32 | pantethine |
| A12AA | Calcium |
| A12AA01 | calcium phosphate |
| A12CE02 | sodium selenite |
| A14AB01 | nandrolone |
| A16AA05 | carglumic acid |
| A16AA06 | betaine |
| A16AX03 | sodium phenylbutyrate |
| A16AX07 | sapropterin |
| B01AA02 | phenindione |
| B01AB05 | enoxaparin |
| B01AB06 | nadroparin |
| B01AC04 | clopidogrel |
| B01AC06 | acetylsalicylic acid |
| B01AC13 | abciximab |
| B01AD11 | tenecteplase |
| B01AF02 | apixaban |
| B02AA01 | aminocaproic acid |
| B02BD05 | coagulation factor VII |
| B02BX02 | carbazochrome |
| B03A | IRON PREPARATIONS |
| B03BA01 | cyanocobalamin |
| B03BA03 | hydroxocobalamin |
| B03XA01 | erythropoietin |
| B05AA05 | dextran |
| B05AA06 | gelatin agents |
| B05AA07 | hydroxyethylstarch |
| B05BC | Solutions producing osmotic diuresis |
| B05CA01 | cetylpyridinium |
| B05CA02 | chlorhexidine |
| B05CA08 | ethacridine lactate |
| B05XA05 | magnesium sulfate |
| B05XX | Other i.v. solution additives |
| B05ZA | Hemodialytics, concentrates |
| B06AA07 | trypsin |
| C01AC01 | g-strophanthin |
| C01CA03 | norepinephrine |
| C01CA04 | dopamine |
| C01CA30 | combinations |
| C01DA14 | isosorbide mononitrate |
| C01EB09 | ubidecarenone |
| C02AA01 | rescinnamine |
| C02AA02 | reserpine |
| C02CA | Alpha-adrenoreceptor antagonists |
| C02DC01 | minoxidil |
| C03BA03 | clopamide |
| C03BA04 | chlortalidone |
| C03CC01 | etacrynic acid |
| A01AB04 | amphotericin B |
| A01AB12 | hexetidine |
| A01AB17 | metronidazole |
| A01AD02 | benzydamine |
| A02AB04 | dihydroxialumini sodium carbonate |
| A02AD04 | hydrotalcite |
| A02BD11 | pantoprazole, amoxicillin, clarithromycin and metronidazole |
| A02BD15 | vonoprazan, amoxicillin and metronidazole |
| A03AA07 | dicycloverine |
| A03AX13 | silicones |
| A03AX14 | valethamate |
| A03BA03 | hyoscyamine |
| A03BB03 | methylscopolamine |
| A03CB03 | atropine and psycholeptics |
| A03DA06 | trospium and analgesics |
| A03EA | Antispasmodics, psycholeptics and analgesics in combination |
| A04AA01 | ondansetron |
| A06AA02 | docusate sodium |
| A06AG04 | glycerol |
| A07 | ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS |
| A07AA05 | polymyxin B |
| A07AA12 | fidaxomicin |
| A07AX03 | nifuroxazide |
| A07FA01 | lactic acid producing organisms |
| A07XA | Other antidiarrheals |
| A09AA | Enzyme preparations |
| A09AA03 | pepsin |
| A09AA04 | tilactase |
| A10AD05 | insulin aspart |
| A10BA02 | metformin |
| A10BB04 | glibornuride |
| A10BB05 | tolazamide |
| A10BD09 | pioglitazone and alogliptin |
| A10BD10 | metformin and saxagliptin |
| A10BD13 | metformin and alogliptin |
| A10BD16 | metformin and canagliflozin |
| A10BD17 | metformin and acarbose |
| A10BD21 | saxagliptin and dapagliflozin |
| A10BD26 | metformin and lobeglitazone |
| A10BF01 | acarbose |
| A10BH01 | sitagliptin |
| A10BH03 | saxagliptin |
| A10BH51 | sitagliptin and simvastatin |
| A10BH52 | gemigliptin and rosuvastatin |
| A10BJ02 | liraglutide |
| A11CC04 | calcitriol |
| A11CC20 | combinations |
| A11EA | Vitamin B-complex, plain |
| A11GB | Ascorbic acid (vitamin C), combinations |
| A11HA02 | pyridoxine (vit B6) |
| A11HA05 | biotin |
| A12AA04 | calcium carbonate |
| A12AA05 | calcium lactate |
| A12BA01 | potassium chloride |
| A12BA05 | potassium gluconate |
| A12CB01 | zinc sulfate |
| A16AX | Various alimentary tract and metabolism products |
| A16AX10 | eliglustat |
| B01AC | Platelet aggregation inhibitors excl. heparin |
| B01AC11 | iloprost |
| B01AC24 | ticagrelor |
| B01AC30 | combinations |
| B01AX05 | fondaparinux |
| B02BA | Vitamin K |
| B02BC06 | thrombin |
| B03AB | Iron trivalent, oral preparations |
| B03AB04 | ferric hydroxide |
| B03AB05 | ferric oxide polymaltose complexes |
| B03AD02 | ferrous fumarate |
| B03AE04 | iron, multivitamins and minerals |
| B03XA02 | darbepoetin alfa |
| B05BC02 | carbamide |
| B05CA09 | neomycin |
| B05CB10 | combinations |
| B05XA | Electrolyte solutions |
| B05XA03 | sodium chloride |
| B05XB02 | alanyl glutamine |
| B05XC | Vitamins |
| B06AA04 | chymotrypsin |
| B06AC05 | lanadelumab |
| C01AA08 | metildigoxin |
| C01CA | Adrenergic and dopaminergic agents |
| C01CA02 | isoprenaline |
| C01CA25 | amezinium metilsulfate |
| C02AB02 | methyldopa (racemic) |
| C02CA01 | prazosin |
| C03AA01 | bendroflumethiazide |
| C03AA03 | hydrochlorothiazide |
| C03AX01 | hydrochlorothiazide, combinations |
| C04AA01 | isoxsuprine |
| C04AF01 | kallidinogenase |
| C04AX | Other peripheral vasodilators |
| C05AB | Antibiotics |
| C05AD01 | lidocaine |
| C05AX05 | tribenoside |
| C05BB04 | sodium tetradecyl sulfate |
| C05BB56 | glucose, combinations |
| C07AA07 | sotalol |
| C07BB03 | atenolol and thiazides |
| C07FB02 | metoprolol and felodipine |
| C07FB07 | bisoprolol and amlodipine |
| C08CA03 | isradipine |
| C08CA04 | nicardipine |
| C08CA13 | lercanidipine |
| C09AA04 | perindopril |
| C09AA05 | ramipril |
| C04AX20 | buflomedil |
| C05AA04 | prednisolone |
| C05AD07 | pramocaine |
| C05AE03 | diltiazem |
| C05AX04 | zinc preparations |
| C05BA53 | heparin, combinations |
| C05BB02 | polidocanol |
| C05BB05 | phenol |
| C07FB03 | atenolol and nifedipine |
| C07FX02 | sotalol and acetylsalicylic acid |
| C07FX04 | bisoprolol and acetylsalicylic acid |
| C08CA07 | nisoldipine |
| C08DA01 | verapamil |
| C09CA02 | eprosartan |
| C09CA03 | valsartan |
| C09DB01 | valsartan and amlodipine |
| C09DB04 | telmisartan and amlodipine |
| C09DX03 | olmesartan medoxomil, amlodipine and hydrochlorothiazide |
| C10AB04 | gemfibrozil |
| C10AC01 | colestyramine |
| C10AD02 | nicotinic acid |
| C10AD52 | nicotinic acid, combinations |
| C10AX | Other lipid modifying agents |
| C10BA03 | pravastatin and fenofibrate |
| C10BX06 | atorvastatin, acetylsalicylic acid and ramipril |
| C10BX13 | rosuvastatin, perindopril and indapamide |
| C10BX14 | rosuvastatin, amlodipine and perindopril |
| D01AC11 | oxiconazole |
| D01AC20 | imidazoles/triazoles in combination with corticosteroids |
| D01AE12 | salicylic acid |
| D01AE22 | naftifine |
| D01BA01 | griseofulvin |
| D03AX06 | becaplermin |
| D03AX14 | Centella asiatica herba |
| D04A | ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. |
| D05AX03 | calcitriol |
| D06AA | Tetracycline and derivatives |
| D06AA03 | oxytetracycline |
| D06AX01 | fusidic acid |
| D06AX04 | neomycin |
| D06BA51 | silver sulfadiazine, combinations |
| D07AA01 | methylprednisolone |
| D07AB11 | hydrocortisone buteprate |
| D07AB19 | dexamethasone |
| D07AC09 | budesonide |
| D07AC17 | fluticasone |
| D07BC02 | fluocinolone acetonide and antiseptics |
| D07CB01 | triamcinolone and antibiotics |
| D07CC | Corticosteroids, potent, combinations with antibiotics |
| D07CC05 | fluocinonide and antibiotics |
| D07XA | Corticosteroids, weak, other combinations |
| D07XC01 | betamethasone |
| D08AC02 | chlorhexidine |
| D08AE01 | hexachlorophene |
| D08AJ | Quaternary ammonium compounds |
| D08AJ01 | benzalkonium |
| D09AA01 | framycetin |
| D10AB | Preparations containing sulfur |
| D10AD01 | tretinoin |
| D10AD03 | adapalene |
| D10AD53 | adapalene, combinations |
| D10AF | Antiinfectives for treatment of acne |
| D11A | OTHER DERMATOLOGICAL PREPARATIONS |
| D11AA | Antihidrotics |
| D11AF | Wart and anti-corn preparations |
| G01AF12 | fenticonazole |
| G01AF19 | sertaconazole |
| G01AX05 | nifuratel |
| G02AB01 | methylergometrine |
| G02AD04 | carboprost |
| G02CB01 | bromocriptine |
| G02CC03 | benzydamine |
| G03AA | Progestogens and estrogens, fixed combinations |
| G03AA09 | desogestrel and ethinylestradiol |
| G03AA10 | gestodene and ethinylestradiol |
| G03AB09 | norgestimate and ethinylestradiol |
| G03AD01 | levonorgestrel |
| G03B | ANDROGENS |
| G03DC01 | allylestrenol |
| G03DC03 | lynestrenol |
| G03FA17 | drospirenone and estrogen |
| G03XA01 | danazol |
| G03XB01 | mifepristone |
| G04CA52 | tamsulosin and dutasteride |
| H02AB05 | paramethasone |
| H05BX02 | paricalcitol |
| H05BX04 | etelcalcetide |
| J01AA02 | doxycycline |
| J01CA02 | pivampicillin |
| J01CA05 | carindacillin |
| J01CF02 | cloxacillin |
| J01DB03 | cefalotin |
| J01DB08 | cefapirin |
| J01DC02 | cefuroxime |
| J01DC10 | cefprozil |
| J01DD01 | cefotaxime |
| J01DD05 | cefmenoxime |
| J01DD06 | latamoxef |
| J01DD08 | cefixime |
| J01DD62 | cefoperazone and beta-lactamase inhibitor |
| J01DI54 | ceftolozane and beta-lactamase inhibitor |
| J01EB02 | sulfamethizole |
| J01ED05 | sulfamethoxypyridazine |
| A01AB | Antiinfectives and antiseptics for local oral treatment |
| A01AB03 | chlorhexidine |
| A01AB18 | clotrimazole |
| A01AC01 | triamcinolone |
| A01AD11 | various |
| A02A | ANTACIDS |
| A02AA10 | combinations |
| A02AF | Antacids with antiflatulents |
| A02BC54 | rabeprazole, combinations |
| A02BD02 | lansoprazole, tetracycline and metronidazole |
| A02BX01 | carbenoxolone |
| A02BX05 | bismuth subcitrate |
| A02BX07 | gefarnate |
| A02X | OTHER DRUGS FOR ACID RELATED DISORDERS |
| A03AB14 | pipenzolate |
| A03AC | Synthetic antispasmodics, amides with tertiary amines |
| A03BB06 | homatropine methylbromide |
| A03CA34 | propantheline and psycholeptics |
| A03FA09 | mosapride |
| A04AA55 | palonosetron, combinations |
| A04AD12 | aprepitant |
| A05AA01 | chenodeoxycholic acid |
| A06AB05 | castor oil |
| A06AB57 | cascara, combinations |
| A06AC | Bulk-forming laxatives |
| A06AD17 | sodium phosphate |
| A07AA07 | amphotericin B |
| A07BA01 | medicinal charcoal |
| A07BC01 | pectin |
| A07DA | Antipropulsives |
| A07EA06 | budesonide |
| A08AA | Centrally acting antiobesity products |
| A10AB01 | insulin (human) |
| A10AD01 | insulin (human) |
| A10BB31 | acetohexamide |
| A10BD04 | glimepiride and rosiglitazone |
| A10BD08 | metformin and vildagliptin |
| A10BD15 | metformin and dapagliflozin |
| A10BD20 | metformin and empagliflozin |
| A10BD23 | metformin and ertugliflozin |
| A10BG03 | pioglitazone |
| A11AA04 | multivitamins and trace elements |
| A11CA | Vitamin A, plain |
| A11CC05 | colecalciferol |
| A11GA01 | ascorbic acid (vit C) |
| A11GB01 | ascorbic acid (vit C) and calcium |
| A11HA04 | riboflavin (vit B2) |
| A11HA30 | dexpanthenol |
| A12AX | Calcium, combinations with vitamin D and/or other drugs |
| A12BA | Potassium |
| A12CC09 | magnesium orotate |
| A12CD | Fluoride |
| A12CD01 | sodium fluoride |
| A16AX14 | migalastat |
| B01AB10 | tinzaparin |
| B01AC17 | tirofiban |
| B01AC23 | cilostazol |
| B01AD | Enzymes |
| B01AD01 | streptokinase |
| B01AE07 | dabigatran etexilate |
| B01AF | Direct factor Xa inhibitors |
| B02AA | Amino acids |
| B02BC30 | combinations |
| B02BD01 | coagulation factor IX, II, VII and X in combination |
| B02BD06 | von Willebrand factor and coagulation factor VIII in combination |
| B02BD30 | thrombin |
| B03AA03 | ferrous gluconate |
| B03AE01 | iron, vitamin B12 and folic acid |
| B03AE02 | iron, multivitamins and folic acid |
| B03AE10 | various combinations |
| B03BA04 | cobamamide |
| B05BA | Solutions for parenteral nutrition |
| B05BA01 | amino acids |
| B05CB | Salt solutions |
| B05XA12 | zinc chloride |
| C01BA01 | quinidine |
| C01BA02 | procainamide |
| C01BA05 | ajmaline |
| C01BC04 | flecainide |
| C02CA04 | doxazosin |
| C02DB | Hydrazinophthalazine derivatives |
| C03AA07 | cyclopenthiazide |
| C04AD02 | xantinol nicotinate |
| C04AX02 | phenoxybenzamine |
| C05AA09 | dexamethasone |
| C05AA12 | triamcinolone |
| C05AD02 | tetracaine |
| C05AE02 | isosorbide dinitrate |
| C05AX02 | bismuth preparations, combinations |
| C07AB03 | atenolol |
| C07AB12 | nebivolol |
| C07AG01 | labetalol |
| C08CA01 | amlodipine |
| C08DA51 | verapamil, combinations |
| C08DB01 | diltiazem |
| C09AA02 | enalapril |
| C09BA02 | enalapril and diuretics |
| C09BB04 | perindopril and amlodipine |
| C09BB07 | ramipril and amlodipine |
| C09DA03 | valsartan and diuretics |
| C09XA02 | aliskiren |
| C10AA02 | lovastatin |
| C10AB01 | clofibrate |
| C10AB05 | fenofibrate |
| C10AA03 | pravastatin |
| C10AX06 | omega-3-triglycerides incl. other esters and acids |
| D01AC | Imidazole and triazole derivatives |
| D01AC05 | isoconazole |
| D01AC15 | fluconazole |
| D01AE15 | terbinafine |
| D01AE20 | combinations |
| D02AF | Salicylic acid preparations |
| D03BA01 | trypsin |
| D04 | ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. |
| D04AA10 | promethazine |
| D04AB02 | cinchocaine |
| D04AX | Other antipruritics |
| D06BA01 | silver sulfadiazine |
| D06BB03 | aciclovir |
| D07AA02 | hydrocortisone |
| D07AA03 | prednisolone |
| D07AC03 | desoximetasone |
| D07AC06 | diflucortolone |
| D07AC13 | mometasone |
| D07AD02 | halcinonide |
| D07BB | Corticosteroids, moderately potent, combinations with antiseptics |
| D07BB03 | triamcinolone and antiseptics |
| D07BC01 | betamethasone and antiseptics |
| D07CB05 | flumetasone and antibiotics |
| D07CC01 | betamethasone and antibiotics |
| D07CC06 | fluocortolone and antibiotics |
| D07XA01 | hydrocortisone |
| D08AD | Boric acid products |
| D08AE05 | chloroxylenol |
| D08AG | Iodine products |
| D08AH01 | dequalinium |
| D08AX05 | isopropanol |
| D08AX06 | potassium permanganate |
| D10AF01 | clindamycin |
| D10AF52 | erythromycin, combinations |
| D11AC01 | cetrimide |
| D11AX01 | minoxidil |
| D11AX11 | hydroquinone |
| D11AX22 | ivermectin |
| G01AA51 | nystatin, combinations |
| G01AB | Arsenic compounds |
| G01AD | Organic acids |
| G01AF02 | clotrimazole |
| G01AF55 | econazole, combinations |
| G02C | OTHER GYNECOLOGICALS |
| G03AA06 | norgestrel and ethinylestradiol |
| G03AA12 | drospirenone and ethinylestradiol |
| G03AC03 | levonorgestrel |
| G03AC10 | drospirenone |
| G03BA02 | methyltestosterone |
| G03BB01 | mesterolone |
| G03CA53 | estradiol, combinations |
| G03CB | Synthetic estrogens, plain |
| G03D | PROGESTOGENS |
| G03DB04 | nomegestrol |
| G03FA10 | norgestrel and estrogen |
| G03FB06 | medroxyprogesterone and estrogen |
| G03HA01 | cyproterone |
| G03XX01 | prasterone |
| G04BD02 | flavoxate |
| G04BD06 | propiverine |
| G04BD08 | solifenacin |
| G04BD12 | mirabegron |
| G04BE10 | avanafil |
| G04CA04 | silodosin |
| G04CA51 | alfuzosin and finasteride |
| H01CC01 | ganirelix |
| H03CA | Iodine therapy |
| H05BA01 | calcitonin (salmon synthetic) |
| J01AA07 | tetracycline |
| J01AA08 | minocycline |
| J01CA01 | ampicillin |
| J01CA03 | carbenicillin |
| J01CA06 | bacampicillin |
| J01CA12 | piperacillin |
| J01CA18 | hetacillin |
| J01CE30 | combinations |
| J01CF01 | dicloxacillin |
| J01CG | Beta-lactamase inhibitors |
| J01DB09 | cefradine |
| J01DC04 | cefaclor |
| J01DD52 | ceftazidime and beta-lactamase inhibitor |
| J01DE01 | cefepime |
| J01DH51 | imipenem and cilastatin |
| J01EB | Short-acting sulfonamides |
| J01EE | Combinations of sulfonamides and trimethoprim, incl. derivatives |
| J01GB03 | gentamicin |
| J01GB06 | amikacin |
| J01GB11 | isepamicin |
| J01MA03 | pefloxacin |
| J01MB07 | flumequine |
| J01MB08 | nemonoxacin |
| J01RA01 | penicillins, combinations with other antibacterials |
| J01RA02 | sulfonamides, combinations with other antibacterials (excl. trimethoprim) |
| J01XC01 | fusidic acid |
| J01XX09 | daptomycin |
| J02AB | Imidazole derivatives |
| J05AP55 | sofosbuvir and velpatasvir |
| J05AR08 | emtricitabine, tenofovir disoproxil and rilpivirine |
| J05AX05 | inosine pranobex |
| J05AX09 | maraviroc |
| J06BA | Immunoglobulins, normal human |
| J06BB02 | tetanus immunoglobulin |
| J07AE | Cholera vaccines |
| C09DX06 | candesartan, amlodipine and hydrochlorothiazide |
| C09XA54 | aliskiren, amlodipine and hydrochlorothiazide |
| C10AB11 | choline fenofibrate |
| C10BX05 | rosuvastatin and acetylsalicylic acid |
| C10BX11 | atorvastatin, amlodipine and perindopril |
| C10BX18 | atorvastatin, amlodipine and ramipril |
| D01AC01 | clotrimazole |
| D01AC09 | sulconazole |
| D01AC12 | fenticonazole |
| D01AE04 | undecylenic acid |
| D03AX03 | dexpanthenol |
| D03BA | Proteolytic enzymes |
| D05AC01 | dithranol |
| D05AX02 | calcipotriol |
| D05BA02 | methoxsalen |
| D06AA01 | demeclocycline |
| D06AX05 | bacitracin |
| D06AX08 | tyrothricin |
| D06AX09 | mupirocin |
| D06BB05 | inosine |
| D06BX01 | metronidazole |
| D07AB02 | hydrocortisone butyrate |
| D07AC02 | fluclorolone |
| D07AC07 | fludroxycortide |
| D07AC10 | diflorasone |
| D07BA01 | prednisolone and antiseptics |
| D07BA04 | hydrocortisone and antiseptics |
| D07BC04 | diflucortolone and antiseptics |
| D07CC04 | beclometasone and antibiotics |
| D08AB | Aluminium agents |
| D08AC | Biguanides and amidines |
| D08AE03 | phenol |
| D08AF01 | nitrofural |
| D08AH03 | oxyquinoline |
| D08AJ08 | benzethonium chloride |
| D10AD51 | tretinoin, combinations |
| D10AF02 | erythromycin |
| D10AF05 | nadifloxacin |
| D11AC03 | selenium compounds |
| D11AH03 | cromoglicic acid |
| D11AX21 | brimonidine |
| D11AX24 | deoxycholic acid |
| G01AA | Antibiotics |
| G01AA03 | amphotericin B |
| G01AX06 | furazolidone |
| G01AX12 | ciclopirox |
| G02AB02 | ergot alkaloids |
| G02AD02 | dinoprostone |
| G02CB02 | lisuride |
| G02CB05 | metergoline |
| G03AA11 | norgestimate and ethinylestradiol |
| G03AC | Progestogens |
| G03AC02 | lynestrenol |
| G03AC05 | megestrol |
| G03BB02 | androstanolone |
| G03CA57 | conjugated estrogens |
| G03CC | Estrogens, combinations with other drugs |
| G03DA04 | progesterone |
| G03DB01 | dydrogesterone |
| G03EK01 | methyltestosterone |
| G03FA05 | methylnortestosterone and estrogen |
| G03GA02 | human menopausal gonadotrophin |
| G03GA05 | follitropin alfa |
| G03GA09 | corifollitropin alfa |
| G03GA30 | combinations |
| G03XB02 | ulipristal |
| G03XC02 | bazedoxifene |
| G04BC | Urinary concrement solvents |
| G04BE01 | alprostadil |
| G04CA01 | alfuzosin |
| H01CB03 | lanreotide |
| H02AB01 | betamethasone |
| H02AB04 | methylprednisolone |
| H02AB07 | prednisone |
| H04AA01 | glucagon |
| J01AA09 | rolitetracycline |
| J01BA02 | thiamphenicol |
| J01CA09 | azlocillin |
| J01CE10 | benzathine phenoxymethylpenicillin |
| J01DB05 | cefadroxil |
| J01DC05 | cefotetan |
| J01DC09 | cefmetazole |
| J01DD04 | ceftriaxone |
| J01DD12 | cefoperazone |
| J01DH03 | ertapenem |
| J01DH04 | doripenem |
| J01DI02 | ceftaroline fosamil |
| J01EB20 | combinations |
| J01EC | Intermediate-acting sulfonamides |
| J01EC02 | sulfadiazine |
| J01ED20 | combinations |
| J01EE01 | sulfamethoxazole and trimethoprim |
| J01FA07 | josamycin |
| J01GB09 | dibekacin |
| J01MA04 | enoxacin |
| J01MA06 | norfloxacin |
| J01RA07 | azithromycin, fluconazole and secnidazole |
| J01RA10 | ciprofloxacin and metronidazole |
| J01XX | Other antibacterials |
| J01XX08 | linezolid |
| J02AA01 | amphotericin B |
| J02AC01 | fluconazole |
| J04AA03 | calcium aminosalicylate |
| J04AB03 | rifamycin |
| J04AK05 | bedaquiline |
| J04AM05 | rifampicin, pyrazinamide and isoniazid |
| J05AE09 | tipranavir |
| J05AF02 | didanosine |
| J05AF07 | tenofovir disoproxil |
| J05AR07 | stavudine, lamivudine and nevirapine |
| C07AA12 | nadolol |
| C07AB02 | metoprolol |
| C07AG02 | carvedilol |
| C07DA06 | timolol, thiazides and other diuretics |
| C07FB12 | nebivolol and amlodipine |
| C07FX03 | metoprolol and acetylsalicylic acid |
| C08CA05 | nifedipine |
| C08CA51 | amlodipine and celecoxib |
| C09AA06 | quinapril |
| C09BA04 | perindopril and diuretics |
| C09BB | ACE inhibitors and calcium channel blockers |
| C09BB02 | enalapril and lercanidipine |
| C09BB03 | lisinopril and amlodipine |
| C09BB05 | ramipril and felodipine |
| C09BX03 | ramipril, amlodipine and hydrochlorothiazide |
| C09CA08 | olmesartan medoxomil |
| C09DA01 | losartan and diuretics |
| C10AB03 | aluminium clofibrate |
| C10AD | Nicotinic acid and derivatives |
| C10BA08 | atorvastatin and omega-3 fatty acids |
| C10BX07 | rosuvastatin, amlodipine and lisinopril |
| C10BX08 | atorvastatin and acetylsalicylic acid |
| C10BX10 | rosuvastatin and valsartan |
| C10BX12 | atorvastatin, acetylsalicylic acid and perindopril |
| D01AA20 | combinations |
| D02AE01 | carbamide |
| D02AX | Other emollients and protectives |
| D03AX | Other cicatrizants |
| D04AA | Antihistamines for topical use |
| D05AA | Tars |
| D05BB01 | etretinate |
| D06AX02 | chloramphenicol |
| D06AX07 | gentamicin |
| D06BA | Sulfonamides |
| D06BA03 | mafenide |
| D06BA06 | sulfamerazine |
| D06BB07 | lysozyme |
| D07AB01 | clobetasone |
| D07AB03 | flumetasone |
| D07AB09 | triamcinolone |
| D07AC05 | fluocortolone |
| D07AC16 | hydrocortisone aceponate |
| D07AD01 | clobetasol |
| D07XB02 | triamcinolone |
| D07XC | Corticosteroids, potent, other combinations |
| D07XC04 | diflucortolone |
| D08A | ANTISEPTICS AND DISINFECTANTS |
| D08AE02 | policresulen |
| D08AG03 | iodine |
| D08AH30 | clioquinol |
| D09AA06 | triclosan |
| D09AA10 | clioquinol |
| D09AA12 | chlorhexidine |
| D10A | ANTI-ACNE PREPARATIONS FOR TOPICAL USE |
| D10AX03 | azelaic acid |
| D11AH02 | pimecrolimus |
| D11AH05 | dupilumab |
| D11AX | Other dermatologicals |
| D11AX03 | calcium gluconate |
| G01AA05 | chloramphenicol |
| G01AD01 | lactic acid |
| G01AF01 | metronidazole |
| G01AF15 | butoconazole |
| G01AG02 | terconazole |
| G02AD01 | dinoprost |
| G02AD05 | sulprostone |
| G02CA01 | ritodrine |
| G02CB03 | cabergoline |
| G03AA01 | etynodiol and ethinylestradiol |
| G03AA03 | lynestrenol and ethinylestradiol |
| G03AA05 | norethisterone and ethinylestradiol |
| G03AA07 | levonorgestrel and ethinylestradiol |
| G03AB02 | lynestrenol and ethinylestradiol |
| G03AB05 | desogestrel and ethinylestradiol |
| G03AC01 | norethisterone |
| G03AC08 | etonogestrel |
| G03AD02 | ulipristal |
| G03BA | 3-oxoandrosten (4) derivatives |
| G03BA03 | testosterone |
| G03CA03 | estradiol |
| G03EA02 | testosterone and estrogen |
| G03FA02 | hydroxyprogesterone and estrogen |
| G03FB01 | norgestrel and estrogen |
| G03GA | Gonadotropins |
| G04BD07 | tolterodine |
| G04BE02 | papaverine |
| G04BE07 | apomorphine |
| G04BX | Other urologicals |
| G04BX01 | magnesium hydroxide |
| G04CB01 | finasteride |
| G04CB02 | dutasteride |
| H01AB01 | thyrotropin alfa |
| H02AB10 | cortisone |
| J01AA06 | oxytetracycline |
| J01CA | Penicillins with extended spectrum |
| J01CE09 | procaine benzylpenicillin |
| J01CR01 | ampicillin and beta-lactamase inhibitor |
| J01DC03 | cefamandole |
| J01DC06 | cefonicid |
| J01DC08 | loracarbef |
| J01DD13 | cefpodoxime |
| J01ED01 | sulfadimethoxine |
| J01EE02 | sulfadiazine and trimethoprim |
| J01EE07 | sulfamerazine and trimethoprim |
| C03DA01 | spironolactone |
| C03EA | Low-ceiling diuretics and potassium-sparing agents |
| C04AC01 | nicotinic acid |
| C04AE04 | dihydroergocristine |
| C04AX01 | cyclandelate |
| C05AA | Corticosteroids |
| C05AA05 | betamethasone |
| C05AA08 | fluocortolone |
| C05BA51 | heparinoid, combinations |
| C07AB07 | bisoprolol |
| C07AB09 | esmolol |
| C07FX06 | carvedilol and ivabradine |
| C08CA02 | felodipine |
| C08CA06 | nimodipine |
| C09AA01 | captopril |
| C09BA03 | lisinopril and diuretics |
| C09BB06 | enalapril and nitrendipine |
| C09BB10 | trandolapril and verapamil |
| C09BX04 | perindopril, bisoprolol and amlodipine |
| C09CA06 | candesartan |
| C09DA06 | candesartan and diuretics |
| C09DB05 | irbesartan and amlodipine |
| C09DX02 | valsartan and aliskiren |
| C10AA04 | fluvastatin |
| C10AD01 | niceritrol |
| C10AD06 | acipimox |
| C10BA06 | rosuvastatin and ezetimibe |
| C10BX03 | atorvastatin and amlodipine |
| C10BX15 | atorvastatin and perindopril |
| D01AA08 | griseofulvin |
| D01AC02 | miconazole |
| D01AC52 | miconazole, combinations |
| D01AE02 | methylrosaniline |
| D01AE16 | amorolfine |
| D03A | CICATRIZANTS |
| D03AX09 | crilanomer |
| D04AA09 | chloropyramine |
| D04AA32 | diphenhydramine |
| D04AB | Anesthetics for topical use |
| D04AB06 | tetracaine |
| D04AB07 | pramocaine |
| D04AX01 | doxepin |
| D05BA | Psoralens for systemic use |
| D06AX12 | amikacin |
| D06BB53 | aciclovir, combinations |
| D06BX02 | ingenol mebutate |
| D06C | ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS |
| D07AB06 | fluorometholone |
| D07AC15 | beclometasone |
| D07CA03 | prednisolone and antibiotics |
| D07XB | Corticosteroids, moderately potent, other combinations |
| D07XB01 | flumetasone |
| D07XB05 | dexamethasone |
| D08AA01 | ethacridine lactate |
| D08AG02 | povidone-iodine |
| D08AJ03 | cetylpyridinium |
| D08AX | Other antiseptics and disinfectants |
| D10AA01 | fluorometholone |
| D10AD54 | isotretinoin, combinations |
| D10AF03 | chloramphenicol |
| D10AF51 | clindamycin, combinations |
| D10AX30 | various combinations |
| D11AC06 | povidone-iodine |
| D11AX10 | finasteride |
| G01AA01 | nystatin |
| G01AC02 | clioquinol |
| G01AF07 | isoconazole |
| G01AF08 | tioconazole |
| G01AF11 | ketoconazole |
| G01AX | Other antiinfectives and antiseptics |
| G02CC01 | ibuprofen |
| G02CX01 | atosiban |
| G03AA08 | medroxyprogesterone and ethinylestradiol |
| G03AA15 | chlormadinone and ethinylestradiol |
| G03AB07 | chlormadinone and ethinylestradiol |
| G03AB08 | dienogest and estradiol |
| G03AC06 | medroxyprogesterone |
| G03CA04 | estriol |
| G03DC06 | etynodiol |
| G03FA01 | norethisterone and estrogen |
| G03GA08 | choriogonadotropin alfa |
| G03HB01 | cyproterone and estrogen |
| G04BE03 | sildenafil |
| G04BE09 | vardenafil |
| G04CX | Other drugs used in benign prostatic hypertrophy |
| H01AC01 | somatropin |
| H01CB02 | octreotide |
| H02AB06 | prednisolone |
| H02CA03 | ketoconazole |
| H03BB01 | carbimazole |
| H03BB02 | thiamazole |
| J01CE01 | benzylpenicillin |
| J01CG02 | tazobactam |
| J01CR02 | amoxicillin and beta-lactamase inhibitor |
| J01CR03 | ticarcillin and beta-lactamase inhibitor |
| J01CR05 | piperacillin and beta-lactamase inhibitor |
| J01D | OTHER BETA-LACTAM ANTIBACTERIALS |
| J01DB01 | cefalexin |
| J01DB02 | cefaloridine |
| J01DC07 | cefotiam |
| J01DD07 | ceftizoxime |
| J01DD14 | ceftibuten |
| J01DE02 | cefpirome |
| J01EA01 | trimethoprim |
| J01EB01 | sulfaisodimidine |
| C09AA09 | fosinopril |
| C09AA10 | trandolapril |
| C09AA16 | imidapril |
| C09DA07 | telmisartan and diuretics |
| C09DB08 | valsartan and lercanidipine |
| C09DX01 | valsartan, amlodipine and hydrochlorothiazide |
| C10AA07 | rosuvastatin |
| C10AA08 | pitavastatin |
| C10AC02 | colestipol |
| C10AX09 | ezetimibe |
| C10AX14 | alirocumab |
| C10BA01 | lovastatin and nicotinic acid |
| C10BA02 | simvastatin and ezetimibe |
| C10BX17 | rosuvastatin and ramipril |
| D01A | ANTIFUNGALS FOR TOPICAL USE |
| D01AA02 | natamycin |
| D01AC14 | sertaconazole |
| D01AE07 | chlorphenesin |
| D01AE23 | butenafine |
| D02AC | Soft paraffin and fat products |
| D04AB01 | lidocaine |
| D06AA04 | tetracycline |
| D06BA04 | sulfamethizole |
| D07AA | Corticosteroids, weak (group I) |
| D07AC04 | fluocinolone acetonide |
| D07AC11 | amcinonide |
| D07BB01 | flumetasone and antiseptics |
| D07CA01 | hydrocortisone and antibiotics |
| D07CA02 | methylprednisolone and antibiotics |
| D07CC02 | fluocinolone acetonide and antibiotics |
| D07X | CORTICOSTEROIDS, OTHER COMBINATIONS |
| D07XB04 | fluorometholone |
| D07XC03 | mometasone |
| D08AX01 | hydrogen peroxide |
| D08AX53 | propanol, combinations |
| D09AA02 | fusidic acid |
| D10AA02 | methylprednisolone |
| D10AA03 | dexamethasone |
| D10AB02 | sulfur |
| D10AB05 | mesulfen |
| D10AX | Other anti-acne preparations for topical use |
| D10BA01 | isotretinoin |
| D11AX13 | monobenzone |
| D11AX26 | caffeine |
| G01AA07 | oxytetracycline |
| G01AC | Quinoline derivatives |
| G01AF06 | ornidazole |
| G01AX11 | povidone-iodine |
| G02B | CONTRACEPTIVES FOR TOPICAL USE |
| G03 | SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM |
| G03AA04 | megestrol and ethinylestradiol |
| G03AA14 | nomegestrol and estradiol |
| G03AA16 | dienogest and ethinylestradiol |
| G03AB01 | megestrol and ethinylestradiol |
| G03AC09 | desogestrel |
| G03BA01 | fluoxymesterone |
| G03CA07 | estrone |
| G03CX01 | tibolone |
| G03DB02 | megestrol |
| G03DC02 | norethisterone |
| G03FA13 | norgestimate and estrogen |
| G03FA15 | dienogest and estrogen |
| G03GA01 | chorionic gonadotrophin |
| G03GA03 | serum gonadotrophin |
| G03GA04 | urofollitropin |
| G03XA02 | gestrinone |
| G03XC01 | raloxifene |
| G04BA01 | ammonium chloride |
| G04BD | Drugs for urinary frequency and incontinence |
| G04BD04 | oxybutynin |
| G04BX14 | dapoxetine |
| G04BX15 | pentosan polysulfate sodium |
| H01BA02 | desmopressin |
| H01BA04 | terlipressin |
| H01CB01 | somatostatin |
| H02AA02 | fludrocortisone |
| H02AB | Glucocorticoids |
| H02AB03 | fluocortolone |
| H02AB08 | triamcinolone |
| H02AB09 | hydrocortisone |
| H03AA05 | thyroid gland preparations |
| H05AA02 | teriparatide |
| J01AA03 | chlortetracycline |
| J01AA12 | tigecycline |
| J01BA01 | chloramphenicol |
| J01CA15 | talampicillin |
| J01CF04 | oxacillin |
| J01DD51 | cefotaxime and beta-lactamase inhibitor |
| J01DD54 | ceftriaxone, combinations |
| J01EB03 | sulfadimidine |
| J01EB06 | sulfanilamide |
| J01FF02 | lincomycin |
| J01GA01 | streptomycin |
| J01GB04 | kanamycin |
| J01MA15 | gemifloxacin |
| J01RA05 | levofloxacin and ornidazole |
| J01XB01 | colistin |
| J01XX01 | fosfomycin |
| J01XX04 | spectinomycin |
| J04AK02 | ethambutol |
| J04AM03 | ethambutol and isoniazid |
| J04AM07 | rifampicin, ethambutol and isoniazid |
| J05AF09 | emtricitabine |
| J05AF10 | entecavir |
| J05AJ01 | raltegravir |
| J05AR09 | emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat |
| J01EE04 | sulfamoxole and trimethoprim |
| J01MA14 | moxifloxacin |
| J01MB02 | nalidixic acid |
| J01MB04 | pipemidic acid |
| J01RA06 | cefepime and amikacin |
| J01RA11 | ciprofloxacin and tinidazole |
| J01RA12 | ciprofloxacin and ornidazole |
| J01XD02 | tinidazole |
| J01XX05 | methenamine |
| J01XX07 | nitroxoline |
| J01XX12 | lefamulin |
| J04AC01 | isoniazid |
| J04AM02 | rifampicin and isoniazid |
| J05AE10 | darunavir |
| J05AF06 | abacavir |
| J05AG03 | efavirenz |
| J05AJ03 | dolutegravir |
| J05AJ04 | cabotegravir |
| J05AR01 | zidovudine and lamivudine |
| J05AR16 | lamivudine and raltegravir |
| J05AR22 | emtricitabine, tenofovir alafenamide, darunavir and cobicistat |
| J05AX02 | lysozyme |
| J06BA02 | immunoglobulins, normal human, for intravascular adm. |
| J07AG51 | haemophilus influenzae B, combinations with toxoids |
| J07BB | Influenza vaccines |
| J07BB01 | influenza, inactivated, whole virus |
| L01AA02 | chlorambucil |
| L01AX03 | temozolomide |
| L01BB05 | fludarabine |
| L01BC07 | azacitidine |
| L01CE01 | topotecan |
| L01EB01 | gefitinib |
| L01EH01 | lapatinib |
| L01EL03 | zanubrutinib |
| L01EX04 | vandetanib |
| L01EX09 | nintedanib |
| L01EX10 | midostaurin |
| L01EX19 | ripretinib |
| L01XC11 | ipilimumab |
| L01XC17 | nivolumab |
| L01XC18 | pembrolizumab |
| L01XC23 | elotuzumab |
| L01XD01 | porfimer sodium |
| L01XG03 | ixazomib |
| L01XX66 | selinexor |
| L02AE01 | buserelin |
| L02BG03 | anastrozole |
| L02BX03 | abiraterone |
| L03AX16 | plerixafor |
| L04AA | Selective immunosuppressants |
| L04AA25 | eculizumab |
| L04AA29 | tofacitinib |
| L04AA31 | teriflunomide |
| L04AA33 | vedolizumab |
| L04AC18 | risankizumab |
| L04AD01 | ciclosporin |
| L04AX04 | lenalidomide |
| M01AB06 | alclofenac |
| M01AB55 | diclofenac, combinations |
| M01AC05 | lornoxicam |
| M01AG01 | mefenamic acid |
| M01AG03 | flufenamic acid |
| M02AA25 | aceclofenac |
| M02AB | Capsaicin and similar agents |
| M03BA02 | carisoprodol |
| M03BB | Oxazol, thiazine, and triazine derivatives |
| M03BB02 | chlormezanone |
| M03BB73 | chlorzoxazone, combinations with psycholeptics |
| M03CA01 | dantrolene |
| M04AA01 | allopurinol |
| M05BA01 | etidronic acid |
| M05BB03 | alendronic acid and colecalciferol |
| M05BB09 | ibandronic acid and colecalciferol |
| M09AB03 | bromelains |
| N01AB04 | enflurane |
| N01AB06 | isoflurane |
| N01AB08 | sevoflurane |
| N01AH01 | fentanyl |
| N01B | ANESTHETICS, LOCAL |
| N01BB03 | mepivacaine |
| N01BB09 | ropivacaine |
| N02AB03 | fentanyl |
| N02AC54 | dextropropoxyphene, combinations excl. psycholeptics |
| N02AE01 | buprenorphine |
| N02AJ14 | tramadol and dexketoprofen |
| N02AJ18 | oxycodone and acetylsalicylic acid |
| N02BA11 | diflunisal |
| N02BA77 | ethenzamide, combinations with psycholeptics |
| N02CA72 | ergotamine, combinations with psycholeptics |
| N02CX02 | clonidine |
| N03AX18 | lacosamide |
| N04A | ANTICHOLINERGIC AGENTS |
| N04BB01 | amantadine |
| N04BD01 | selegiline |
| N05AE04 | ziprasidone |
| N05AE05 | lurasidone |
| N05AH03 | olanzapine |
| N05AX13 | paliperidone |
| N05BA16 | nordazepam |
| N05CA02 | amobarbital |
| N05CD03 | flunitrazepam |
| N05CD05 | triazolam |
| N05CM11 | bromides |
| N05CM18 | dexmedetomidine |
| N06AB06 | sertraline |
| N06BA04 | methylphenidate |
| N06BA07 | modafinil |
| N06DA03 | rivastigmine |
| J07AF01 | diphtheria toxoid |
| J07AL02 | pneumococcus, purified polysaccharides antigen conjugated |
| J07AL52 | pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated |
| J07AM01 | tetanus toxoid |
| J07BF02 | poliomyelitis oral, trivalent, live attenuated |
| J07BK01 | varicella, live attenuated |
| J07CA | Bacterial and viral vaccines, combined |
| L01AA09 | bendamustine |
| L01AC01 | thiotepa |
| L01AD01 | carmustine |
| L01BA04 | pemetrexed |
| L01BC53 | tegafur, combinations |
| L01DB02 | daunorubicin |
| L01EB03 | afatinib |
| L01EC01 | vemurafenib |
| L01EE04 | selumetinib |
| L01EF01 | palbociclib |
| L01EM02 | copanlisib |
| L01EX08 | lenvatinib |
| L01XA03 | oxaliplatin |
| L01XC13 | pertuzumab |
| L01XH01 | vorinostat |
| L01XX05 | hydroxycarbamide |
| L01XX33 | celecoxib |
| L02AE02 | leuprorelin |
| L02BA03 | fulvestrant |
| L02BB01 | flutamide |
| L02BB05 | apalutamide |
| L02BG04 | letrozole |
| L02BG06 | exemestane |
| L04AA06 | mycophenolic acid |
| L04AA26 | belimumab |
| L04AB07 | opinercept |
| L04AX | Other immunosuppressants |
| L04AX03 | methotrexate |
| M01AB16 | aceclofenac |
| M01AB51 | indometacin, combinations |
| M01AC01 | piroxicam |
| M01AE08 | pirprofen |
| M01AE12 | oxaprozin |
| M01AX02 | niflumic acid |
| M02AA07 | piroxicam |
| M03BA01 | phenprobamate |
| M03BX01 | baclofen |
| M09AX07 | nusinersen |
| M09AX10 | risdiplam |
| N01AX03 | ketamine |
| N01BC01 | cocaine |
| N02AA51 | morphine, combinations |
| N02AA59 | codeine, combinations excl. psycholeptics |
| N02AB02 | pethidine |
| N02AC04 | dextropropoxyphene |
| N02AC52 | methadone, combinations excl. psycholeptics |
| N02AF02 | nalbuphine |
| N02AG | Opioids in combination with antispasmodics |
| N02AG01 | morphine and antispasmodics |
| N02AJ06 | codeine and paracetamol |
| N02BA05 | salicylamide |
| N02BA06 | salsalate |
| N02BA51 | acetylsalicylic acid, combinations excl. psycholeptics |
| N02BA71 | acetylsalicylic acid, combinations with psycholeptics |
| N02BB01 | phenazone |
| N02BB54 | propyphenazone, combinations excl. psycholeptics |
| N02BE | Anilides |
| N02BE53 | phenacetin, combinations excl. psycholeptics |
| N02CA52 | ergotamine, combinations excl. psycholeptics |
| N02CC01 | sumatriptan |
| N02CC03 | zolmitriptan |
| N03AA | Barbiturates and derivatives |
| N03AG01 | valproic acid |
| N04AC01 | benzatropine |
| N04BA02 | levodopa and decarboxylase inhibitor |
| N04BA03 | levodopa, decarboxylase inhibitor and COMT inhibitor |
| N04BA05 | melevodopa and decarboxylase inhibitor |
| N05AA02 | levomepromazine |
| N05AC02 | thioridazine |
| N05AF05 | zuclopenthixol |
| N05AH02 | clozapine |
| N05AL07 | levosulpiride |
| N05AX11 | zotepine |
| N05AX12 | aripiprazole |
| N05BA01 | diazepam |
| N05BA03 | medazepam |
| N05CD02 | nitrazepam |
| N05CD06 | lormetazepam |
| N05CF01 | zopiclone |
| N05CH02 | ramelteon |
| N05CX01 | meprobamate, combinations |
| N06AA02 | imipramine |
| N06AA06 | trimipramine |
| N06AB05 | paroxetine |
| N06AX06 | nefazodone |
| N06AX17 | milnacipran |
| N06BX01 | meclofenoxate |
| N06DA53 | donepezil, memantine and Ginkgo folium |
| N07AB02 | bethanechol |
| N07BA01 | nicotine |
| N07BB04 | naltrexone |
| N07BC01 | buprenorphine |
| P02BX | Other antitrematodal agents |
| P02C | ANTINEMATODAL AGENTS |
| P02CB01 | piperazine |
| R01AA05 | oxymetazoline |
| R01AB07 | oxymetazoline |
| R01AD53 | dexamethasone, combinations |
| R01AX | Other nasal preparations |
| R01BA | Sympathomimetics |
| C10BA07 | rosuvastatin and omega-3 fatty acids |
| C10BA09 | rosuvastatin and fenofibrate |
| C10BX02 | pravastatin and acetylsalicylic acid |
| C10BX09 | rosuvastatin and amlodipine |
| D01AC03 | econazole |
| D01AC07 | tioconazole |
| D01AE | Other antifungals for topical use |
| D01AE13 | selenium sulfide |
| D02AE51 | carbamide, combinations |
| D02BB01 | betacarotene |
| D03AX10 | enoxolone |
| D03BA03 | bromelains |
| D04AA02 | mepyramine |
| D04AB04 | benzocaine |
| D05AC51 | dithranol, combinations |
| D05BA01 | trioxysalen |
| D05BB02 | acitretin |
| D06BA05 | sulfanilamide |
| D06BB04 | podophyllotoxin |
| D06BB10 | imiquimod |
| D06BX | Other chemotherapeutics |
| D07AC01 | betamethasone |
| D07AC08 | fluocinonide |
| D07AC14 | methylprednisolone aceponate |
| D07CB04 | dexamethasone and antibiotics |
| D07XC02 | desoximetasone |
| D08AC52 | chlorhexidine, combinations |
| D08AE04 | triclosan |
| D08AK04 | merbromin |
| D08AK06 | thiomersal |
| D08AX08 | ethanol |
| D09AA03 | nitrofural |
| D09AA07 | cetylpyridinium |
| D09AA11 | benzalkonium |
| D10AD02 | retinol |
| D11AH01 | tacrolimus |
| D11AX12 | pyrithione zinc |
| G01AA10 | clindamycin |
| G01AF05 | econazole |
| G01AX03 | policresulen |
| G02AD06 | misoprostol |
| G02CA03 | fenoterol |
| G03AA13 | norelgestromin and ethinylestradiol |
| G03AA18 | drospirenone and estetrol |
| G03AB03 | levonorgestrel and ethinylestradiol |
| G03AB04 | norethisterone and ethinylestradiol |
| G03AB06 | gestodene and ethinylestradiol |
| G03DA02 | medroxyprogesterone |
| G03DA03 | hydroxyprogesterone |
| G03DB08 | dienogest |
| G03EA01 | methyltestosterone and estrogen |
| G03EB | Androgen, progestogen and estrogen in combination |
| G03FA12 | medroxyprogesterone and estrogen |
| G03FB05 | norethisterone and estrogen |
| G03GA06 | follitropin beta |
| G04BA03 | calcium chloride |
| G04BD09 | trospium |
| G04BE08 | tadalafil |
| G04CA54 | tamsulosin and tadalafil |
| H01AC03 | mecasermin |
| H01BA01 | vasopressin (argipressin) |
| H01BB02 | oxytocin |
| H01BB03 | carbetocin |
| H01CB05 | pasireotide |
| H03AA01 | levothyroxine sodium |
| H03AA02 | liothyronine sodium |
| H03BA02 | propylthiouracil |
| J01AA01 | demeclocycline |
| J01CA04 | amoxicillin |
| J01CA08 | pivmecillinam |
| J01CA16 | sulbenicillin |
| J01CA51 | ampicillin, combinations |
| J01CF05 | flucloxacillin |
| J01CG01 | sulbactam |
| J01CR04 | sultamicillin |
| J01DB04 | cefazolin |
| J01DC01 | cefoxitin |
| J01DD02 | ceftazidime |
| J01DF01 | aztreonam |
| J01DH02 | meropenem |
| J01EB05 | sulfafurazole |
| J01EC01 | sulfamethoxazole |
| J01EC20 | combinations |
| J01EE05 | sulfadimidine and trimethoprim |
| J01FA03 | midecamycin |
| J01FA08 | troleandomycin |
| J01FA09 | clarithromycin |
| J01GB01 | tobramycin |
| J01GB05 | neomycin |
| J01MA12 | levofloxacin |
| J01MB06 | cinoxacin |
| J01RA03 | cefuroxime and metronidazole |
| J02AB01 | miconazole |
| J02AX | Other antimycotics for systemic use |
| J04AK01 | pyrazinamide |
| J05AB14 | valganciclovir |
| J05AE08 | atazanavir |
| J05AF03 | zalcitabine |
| J05AF04 | stavudine |
| J05AR12 | lamivudine and tenofovir disoproxil |
| J06BB01 | anti-D (rh) immunoglobulin |
| J07AH10 | meningococcus A, purified polysaccharides antigen conjugated |
| J07BF | Poliomyelitis vaccines |
| J07BH01 | rota virus, live attenuated |
| J07CA09 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B |
| L01BA01 | methotrexate |
| L01BC06 | capecitabine |
| L01BC08 | decitabine |
| L01DC01 | bleomycin |
| A01AA04 | stannous fluoride |
| A01AB08 | neomycin |
| A01AC02 | dexamethasone |
| A01AD | Other agents for local oral treatment |
| A02AA04 | magnesium hydroxide |
| A02AB01 | aluminium hydroxide |
| A02AD02 | magaldrate |
| A02AF02 | ordinary salt combinations and antiflatulents |
| A02AH | Antacids with sodium bicarbonate |
| A02AX | Antacids, other combinations |
| A02BA04 | nizatidine |
| A02BC02 | pantoprazole |
| A02BC06 | dexlansoprazole |
| A02BC08 | vonoprazan |
| A02BD03 | lansoprazole, amoxicillin and metronidazole |
| A02BD07 | lansoprazole, amoxicillin and clarithromycin |
| A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
| A02BX12 | bismuth subnitrate |
| A02BX13 | alginic acid |
| A03 | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03AA | Synthetic anticholinergics, esters with tertiary amino group |
| A03AB06 | otilonium bromide |
| A03AX03 | chlorbenzoxamine |
| A03AX08 | alverine |
| A03CC | Other antispasmodics in combination with psycholeptics |
| A04AA | Serotonin (5HT3) antagonists |
| A04AA02 | granisetron |
| A04AD51 | scopolamine, combinations |
| A05BA01 | arginine glutamate |
| A06AB02 | bisacodyl |
| A06AB07 | cascara |
| A06AB58 | sodium picosulfate, combinations |
| A06AC53 | sterculia, combinations |
| A06AG | Enemas |
| A07AA02 | nystatin |
| A07AA04 | streptomycin |
| A07BB | Bismuth preparations |
| A07BC | Other intestinal adsorbents |
| A07BC30 | combinations |
| A07CA | Oral rehydration salt formulations |
| A07DA52 | morphine, combinations |
| A07EA04 | betamethasone |
| A07EC02 | mesalazine |
| A07EC04 | balsalazide |
| A08AA11 | lorcaserin |
| A09AA02 | multienzymes (lipase, protease etc.) |
| A09AB01 | glutamic acid hydrochloride |
| A10AC01 | insulin (human) |
| A10AD | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting |
| A10BA03 | buformin |
| A10BB03 | tolbutamide |
| A10BD | Combinations of oral blood glucose lowering drugs |
| A10BD25 | metformin, saxagliptin and dapagliflozin |
| A11AA01 | multivitamins and iron |
| A11CA01 | retinol (vit A) |
| A11DA | Vitamin B1, plain |
| A11HA06 | pyridoxal phosphate |
| A12AA07 | calcium chloride |
| A12AA10 | calcium glucoheptonate |
| A12AA13 | calcium citrate |
| A12CC02 | magnesium sulfate |
| A12CC05 | magnesium aspartate |
| A12CE | Selenium |
| A14AA | Androstan derivatives |
| A14AA08 | oxandrolone |
| A16A | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| A16AA03 | glutamine |
| A16AX02 | anethole trithione |
| B01AB51 | heparin, combinations |
| B01AC09 | epoprostenol |
| B01AC56 | acetylsalicylic acid, combinations with proton pump inhibitors |
| B01AE06 | bivalirudin |
| B01AX | Other antithrombotic agents |
| B02BA01 | phytomenadione |
| B02BD07 | coagulation factor XIII |
| B02BD08 | coagulation factor VIIa |
| B02BD13 | coagulation factor X |
| B02BX05 | eltrombopag |
| B03AA | Iron bivalent, oral preparations |
| B03AA02 | ferrous fumarate |
| B03AA07 | ferrous sulfate |
| B03AC | Iron, parenteral preparations |
| B03AE | Iron in other combinations |
| B03BB01 | folic acid |
| B05AA | Blood substitutes and plasma protein fractions |
| B05CB01 | sodium chloride |
| B05CB02 | sodium citrate |
| B05CX | Other irrigating solutions |
| B05CX02 | sorbitol |
| B05XA06 | potassium phosphate, incl. combinations with other potassium salts |
| B05XA14 | sodium glycerophosphate |
| B05XA16 | cardioplegia solutions |
| B05XB01 | arginine hydrochloride |
| C01BD01 | amiodarone |
| C01BD02 | bretylium tosilate |
| J06BB04 | hepatitis B immunoglobulin |
| J06BB09 | cytomegalovirus immunoglobulin |
| J07AG01 | haemophilus influenzae B, purified antigen conjugated |
| J07AJ | Pertussis vaccines |
| J07AM51 | tetanus toxoid, combinations with diphtheria toxoid |
| J07AP | Typhoid vaccines |
| J07BB02 | influenza, inactivated, split virus or surface antigen |
| J07BC20 | combinations |
| J07BD52 | measles, combinations with mumps and rubella, live attenuated |
| J07BK03 | zoster, purified antigen |
| J07BM01 | papillomavirus (human types 6, 11, 16, 18) |
| J07BM02 | papillomavirus (human types 16, 18) |
| J07CA02 | diphtheria-pertussis-poliomyelitis-tetanus |
| J07CA06 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus |
| L01AX04 | dacarbazine |
| L01CA01 | vinblastine |
| L01CE02 | irinotecan |
| L01DB07 | mitoxantrone |
| L01ED04 | brigatinib |
| L01ED05 | lorlatinib |
| L01EF02 | ribociclib |
| L01EX01 | sunitinib |
| L01EX13 | gilteritinib |
| L01XA01 | cisplatin |
| L01XC15 | obinutuzumab |
| L01XX | Other antineoplastic agents |
| L01XX71 | tisagenlecleucel |
| L02AA | Estrogens |
| L02BB03 | bicalutamide |
| L02BB06 | darolutamide |
| L04AA27 | fingolimod |
| L04AB01 | etanercept |
| L04AB05 | certolizumab pegol |
| L04AC08 | canakinumab |
| M01AB03 | tolmetin |
| M01AC02 | tenoxicam |
| M01AC06 | meloxicam |
| M01AE02 | naproxen |
| M01AE03 | ketoprofen |
| M01AE53 | ketoprofen, combinations |
| M01AG02 | tolfenamic acid |
| M01AH05 | etoricoxib |
| M01AX01 | nabumetone |
| M01BA03 | acetylsalicylic acid and corticosteroids |
| M02AA12 | naproxen |
| M02AB01 | capsaicin |
| M03BA03 | methocarbamol |
| M03BX03 | pridinol |
| M04AB01 | probenecid |
| M05BA02 | clodronic acid |
| M05BA06 | ibandronic acid |
| M05BB07 | risedronic acid and colecalciferol |
| M05BX05 | burosumab |
| M05BX53 | strontium ranelate and colecalciferol |
| N01BB06 | cinchocaine |
| N01BB53 | mepivacaine, combinations |
| N01BB58 | articaine, combinations |
| N01BX | Other local anesthetics |
| N02AA01 | morphine |
| N02AA05 | oxycodone |
| N02AF01 | butorphanol |
| N02AJ09 | codeine and other non-opioid analgesics |
| N02AJ13 | tramadol and paracetamol |
| N02BA04 | sodium salicylate |
| N02BE01 | paracetamol |
| N03AE01 | clonazepam |
| N03AF01 | carbamazepine |
| N03AF02 | oxcarbazepine |
| N03AX09 | lamotrigine |
| N04BA | Dopa and dopa derivatives |
| N04BD03 | safinamide |
| N05AA01 | chlorpromazine |
| N05AA05 | triflupromazine |
| N05AF01 | flupentixol |
| N05AL05 | amisulpride |
| N05BA | Benzodiazepine derivatives |
| N05BA09 | clobazam |
| N05BA11 | prazepam |
| N05BA22 | cloxazolam |
| N05CD04 | estazolam |
| N05CF03 | zaleplon |
| N06AA03 | imipramine oxide |
| N06AA16 | dosulepin |
| N06AB04 | citalopram |
| N06AX16 | venlafaxine |
| N06CA02 | melitracen and psycholeptics |
| N06DA04 | galantamine |
| N07AA01 | neostigmine |
| N07AX01 | pilocarpine |
| N07BA03 | varenicline |
| N07CA02 | cinnarizine |
| N07XX06 | tetrabenazine |
| N07XX11 | pitolisant |
| N07XX59 | dextromethorphan, combinations |
| P01AA02 | clioquinol |
| P01AB01 | metronidazole |
| P03AA | Sulfur containing products |
| P03AB02 | lindane |
| P03AC03 | phenothrin |
| R01AA07 | xylometazoline |
| R01AB06 | xylometazoline |
| R01AC02 | levocabastine |
| R01AD | Corticosteroids |
| R01AD01 | beclometasone |
| R01AD12 | fluticasone furoate |
| R01AX02 | retinol |
| R02AA02 | dequalinium |
| R02AB02 | tyrothricin |
| R02AX02 | ibuprofen |
| R03AK01 | epinephrine and other drugs for obstructive airway diseases |
| R01BA02 | pseudoephedrine |
| R02AA16 | benzalkonium |
| R03AB02 | isoprenaline |
| R03AC04 | fenoterol |
| R03AC12 | salmeterol |
| R03AC16 | procaterol |
| R03AL03 | vilanterol and umeclidinium bromide |
| R03AL11 | formoterol, glycopyrronium bromide and budesonide |
| R03AL12 | indacaterol, glycopyrronium bromide and mometasone |
| R03CC53 | terbutaline, combinations |
| R03DB05 | aminophylline and adrenergics |
| R03DX03 | fenspiride |
| R05CA | Expectorants |
| R05CA08 | creosote |
| R05CA10 | combinations |
| R05DA | Opium alkaloids and derivatives |
| R05DA05 | opium alkaloids with morphine |
| R06AA57 | diphenylpyraline, combinations |
| R06AX26 | fexofenadine |
| R06AX27 | desloratadine |
| R07AB02 | nikethamide |
| S01AA19 | ampicillin |
| S01AA27 | cefuroxime |
| S01AA30 | combinations of different antibiotics |
| S01AB04 | sulfacetamide |
| S01AX04 | nitrofural |
| S01BA03 | cortisone |
| S01BA04 | prednisolone |
| S01BA09 | clobetasone |
| S01BA15 | fluocinolone acetonide |
| S01BB02 | prednisolone and mydriatics |
| S01BC11 | bromfenac |
| S01CA05 | betamethasone and antiinfectives |
| S01CA10 | fluocinolone acetonide and antiinfectives |
| S01CB02 | prednisolone |
| S01CC01 | diclofenac and antiinfectives |
| S01EB02 | carbachol |
| S01ED51 | timolol, combinations |
| S01EE02 | unoprostone |
| S01FA02 | scopolamine |
| S01GA03 | xylometazoline |
| S01GX05 | lodoxamide |
| S01GX10 | epinastine |
| S01HA05 | procaine |
| S01KA | Viscoelastic substances |
| S01LA05 | aflibercept |
| S01XA08 | acetylcysteine |
| S01XA15 | ascorbic acid |
| S02AA07 | neomycin |
| S02CA03 | hydrocortisone and antiinfectives |
| S03AA08 | chloramphenicol |
| V03AB01 | ipecacuanha |
| V03AB02 | nalorphine |
| V03AB04 | pralidoxime |
| V03AB17 | methylthioninium chloride |
| V03AB21 | potassium iodide |
| V03AB26 | methionine |
| V03AE01 | polystyrene sulfonate |
| V03AX03 | cobicistat |
| V04CE01 | galactose |
| V04CX09 | patent blue |
| V06DC02 | fructose |
| V09EX | Other respiratory system diagnostic radiopharmaceuticals |
| V09FX02 | sodium iodide (123I) |
| V09X | OTHER DIAGNOSTIC RADIOPHARMACEUTICALS |
| V09XA01 | iodine (131I) norcholesterol |
| C01CA24 | epinephrine |
| C01DX02 | prenylamine |
| C01EA01 | alprostadil |
| C01EB03 | indometacin |
| C01EB21 | regadenoson |
| C02AA52 | reserpine, combinations |
| C03AA02 | hydroflumethiazide |
| C03AB03 | hydrochlorothiazide and potassium |
| C03BA08 | metolazone |
| C03EB02 | bumetanide and potassium-sparing agents |
| C03XA01 | tolvaptan |
| C04AC | Nicotinic acid and derivatives |
| C04AD03 | pentoxifylline |
| C05 | VASOPROTECTIVES |
| C05AA06 | fluorometholone |
| C05AA11 | fluocinonide |
| C05AD04 | cinchocaine |
| C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use |
| C05B | ANTIVARICOSE THERAPY |
| C05CA | Bioflavonoids |
| C05CA01 | rutoside |
| C05CA04 | troxerutin |
| C07AA | Beta blocking agents, non-selective |
| C07AA02 | oxprenolol |
| C07AA03 | pindolol |
| C07AA16 | tertatolol |
| C07AB04 | acebutolol |
| C07AB05 | betaxolol |
| C07BA06 | timolol and thiazides |
| C08CA12 | barnidipine |
| C08CA55 | nifedipine, combinations |
| C08GA02 | amlodipine and diuretics |
| C09AA03 | lisinopril |
| C09AA08 | cilazapril |
| C09DA04 | irbesartan and diuretics |
| C09DB06 | losartan and amlodipine |
| C09DX05 | valsartan and nebivolol |
| C09XA53 | aliskiren and amlodipine |
| C10AA01 | simvastatin |
| C10AA05 | atorvastatin |
| C10AB02 | bezafibrate |
| C10AB06 | simfibrate |
| C10AB09 | etofibrate |
| C10AC | Bile acid sequestrants |
| C10AC04 | colesevelam |
| C10AX02 | probucol |
| C10AX12 | lomitapide |
| C10AX13 | evolocumab |
| C10BA04 | simvastatin and fenofibrate |
| C10BA05 | atorvastatin and ezetimibe |
| C10BX01 | simvastatin and acetylsalicylic acid |
| C10BX04 | simvastatin, acetylsalicylic acid and ramipril |
| C10BX16 | rosuvastatin and fimasartan |
| D01AA01 | nystatin |
| D01AC08 | ketoconazole |
| D01AC10 | bifonazole |
| D01AE14 | ciclopirox |
| D01AE18 | tolnaftate |
| D01AE54 | undecylenic acid, combinations |
| D01BA02 | terbinafine |
| D02AB | Zinc products |
| D02AE | Carbamide products |
| D02BA02 | octinoxate |
| D03 | PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS |
| D03AA | Cod-liver oil ointments |
| D03AX01 | cadexomer iodine |
| D03AX04 | calcium pantothenate |
| D03B | ENZYMES |
| D04AA14 | clemastine |
| D04AA34 | chlorphenoxamine |
| D05AX05 | tazarotene |
| D05AX52 | calcipotriol, combinations |
| D06AA02 | chlortetracycline |
| D06AX | Other antibiotics for topical use |
| D06BB02 | tromantadine |
| D06BB06 | penciclovir |
| D07BB04 | hydrocortisone butyrate and antiseptics |
| D07CA | Corticosteroids, weak, combinations with antibiotics |
| D07CD01 | clobetasol and antibiotics |
| D07XA02 | prednisolone |
| D08AE | Phenol and derivatives |
| D08AJ02 | cetrimonium |
| D08AJ04 | cetrimide |
| D08AJ58 | benzethonium chloride, combinations |
| D09AA | Medicated dressings with antiinfectives |
| D09AA09 | povidone-iodine |
| D10AD | Retinoids for topical use in acne |
| D10AD04 | isotretinoin |
| D10AE01 | benzoyl peroxide |
| D10AE51 | benzoyl peroxide, combinations |
| D10AX02 | resorcinol |
| D11AC | Medicated shampoos |
| D11AE | Androgens for topical use |
| D11AH06 | crisaborole |
| D11AX05 | magnesium sulfate |
| D11AX18 | diclofenac |
| D11AX57 | collagen, combinations |
| G01AD03 | ascorbic acid |
| G01AE01 | sulfatolamide |
| G01AF04 | miconazole |
| G01AX02 | inosine |
| G02AB | Ergot alkaloids |
| G02AB03 | ergometrine |
| G02AC01 | methylergometrine and oxytocin |
| G02AD | Prostaglandins |
| G02CC02 | naproxen |
| G03AA02 | quingestanol and ethinylestradiol |
| J01FA06 | roxithromycin |
| J01FA10 | azithromycin |
| J01MA02 | ciprofloxacin |
| J01MB05 | oxolinic acid |
| J01XA02 | teicoplanin |
| J01XX11 | tedizolid |
| J02AC04 | posaconazole |
| J02AX05 | micafungin |
| J04AA | Aminosalicylic acid and derivatives |
| J04AB02 | rifampicin |
| J04BA02 | dapsone |
| J05AB | Nucleosides and nucleotides excl. reverse transcriptase inhibitors |
| J05AE | Protease inhibitors |
| J05AE03 | ritonavir |
| J05AP07 | daclatasvir |
| J05AP08 | sofosbuvir |
| J05AP51 | sofosbuvir and ledipasvir |
| J05AP56 | sofosbuvir, velpatasvir and voxilaprevir |
| J05AR25 | lamivudine and dolutegravir |
| J05AX29 | fostemsavir |
| J06B | IMMUNOGLOBULINS |
| J07AG52 | haemophilus influenzae B, combinations with pertussis and toxoids |
| J07AH07 | meningococcus C, purified polysaccharides antigen conjugated |
| J07AH08 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated |
| J07AL01 | pneumococcus, purified polysaccharides antigen |
| J07BD01 | measles, live attenuated |
| J07BF01 | poliomyelitis oral, monovalent, live attenuated |
| J07BF03 | poliomyelitis, trivalent, inactivated, whole virus |
| J07BF04 | poliomyelitis oral, bivalent, live attenuated |
| L01BB03 | tioguanine |
| L01BB06 | clofarabine |
| L01BC | Pyrimidine analogues |
| L01BC52 | fluorouracil, combinations |
| L01CA02 | vincristine |
| L01CB01 | etoposide |
| L01CD01 | paclitaxel |
| L01DB03 | epirubicin |
| L01EA05 | ponatinib |
| L01EB02 | erlotinib |
| L01EH02 | neratinib |
| L01EX14 | entrectinib |
| L01EX18 | avapritinib |
| L01XC06 | cetuximab |
| L01XC07 | bevacizumab |
| L01XC16 | dinutuximab beta |
| L01XC21 | ramucirumab |
| L01XC28 | durvalumab |
| L01XC41 | trastuzumab deruxtecan |
| L01XG02 | carfilzomib |
| L01XK04 | talazoparib |
| L01XX41 | eribulin |
| L01XX44 | aflibercept |
| L01XY02 | pertuzumab and trastuzumab |
| L02AB02 | medroxyprogesterone |
| L02AE04 | triptorelin |
| L02BA01 | tamoxifen |
| L02BA02 | toremifene |
| L03AA02 | filgrastim |
| L03AA10 | lenograstim |
| L03AA13 | pegfilgrastim |
| L03AB08 | interferon beta-1b |
| L04AA13 | leflunomide |
| L04AA23 | natalizumab |
| L04AA24 | abatacept |
| L04AX06 | pomalidomide |
| L04AX07 | dimethyl fumarate |
| M01AB01 | indometacin |
| M01AB02 | sulindac |
| M01AC56 | meloxicam, combinations |
| M01AE16 | alminoprofen |
| M01AH01 | celecoxib |
| M01AX07 | benzydamine |
| M02A | TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
| M02AA26 | nimesulide |
| M03BA52 | carisoprodol, combinations excl. psycholeptics |
| M03BC51 | orphenadrine, combinations |
| M03BX02 | tizanidine |
| M05BB04 | risedronic acid, calcium and colecalciferol, sequential |
| M05BB06 | alendronic acid and alfacalcidol, sequential |
| N01AF01 | methohexital |
| N01AX13 | nitrous oxide |
| N01BA | Esters of aminobenzoic acid |
| N01BB01 | bupivacaine |
| N02AJ01 | dihydrocodeine and paracetamol |
| N02BA03 | choline salicylate |
| N02BB03 | aminophenazone |
| N02BE03 | phenacetin |
| N02BE71 | paracetamol, combinations with psycholeptics |
| N02BG06 | nefopam |
| N02BG09 | methoxyflurane |
| N02CA01 | dihydroergotamine |
| N02CC04 | rizatriptan |
| N03AB02 | phenytoin |
| N03AG04 | vigabatrin |
| N03AX15 | zonisamide |
| N03AX22 | perampanel |
| N04BA06 | etilevodopa and decarboxylase inhibitor |
| N04BC02 | pergolide |
| N05AB03 | perphenazine |
| N05AD01 | haloperidol |
| N05BA12 | alprazolam |
| N05CA01 | pentobarbital |
| N05CC01 | chloral hydrate |
| N05CF02 | zolpidem |
| L01EA03 | nilotinib |
| L01EC02 | dabrafenib |
| L01ED03 | alectinib |
| L01EF03 | abemaciclib |
| L01EX02 | sorafenib |
| L01EX03 | pazopanib |
| L01EX15 | pexidartinib |
| L01EX20 | pemigatinib |
| L01XC03 | trastuzumab |
| L01XC12 | brentuximab vedotin |
| L01XC19 | blinatumomab |
| L01XG01 | bortezomib |
| L01XX27 | arsenic trioxide |
| L02AA03 | ethinylestradiol |
| L02AB01 | megestrol |
| L02BG01 | aminoglutethimide |
| L03AB10 | peginterferon alfa-2b |
| L03AX15 | mifamurtide |
| L04AA04 | antithymocyte immunoglobulin (rabbit) |
| L04AA21 | efalizumab |
| L04AA40 | cladribine |
| L04AA42 | siponimod |
| L04AA44 | upadacitinib |
| L04AB04 | adalimumab |
| L04AC05 | ustekinumab |
| M01AA01 | phenylbutazone |
| M01AB08 | etodolac |
| M01AB11 | acemetacin |
| M01AE04 | fenoprofen |
| M01AE17 | dexketoprofen |
| M01AH04 | parecoxib |
| M01BX | Other antiinflammatory/antirheumatic agents in combination with other drugs |
| M02AA05 | benzydamine |
| M02AA09 | bufexamac |
| M02AA21 | tolmetin |
| M02AX | Other topical products for joint and muscular pain |
| M03AB01 | suxamethonium |
| M03AC10 | mivacurium chloride |
| M03AC11 | cisatracurium |
| M03AX01 | botulinum toxin |
| M03BX08 | cyclobenzaprine |
| M03BX09 | eperisone |
| M04AB | Preparations increasing uric acid excretion |
| M04AB02 | sulfinpyrazone |
| M05BA03 | pamidronic acid |
| M05BA04 | alendronic acid |
| M05BA07 | risedronic acid |
| M05BX03 | strontium ranelate |
| M09AB | Enzymes |
| N01AH02 | alfentanil |
| N01AH06 | remifentanil |
| N01BA03 | tetracaine |
| N01BB08 | articaine |
| N01BB10 | levobupivacaine |
| N01BB51 | bupivacaine, combinations |
| N02AA02 | opium |
| N02AA03 | hydromorphone |
| N02AJ02 | dihydrocodeine and acetylsalicylic acid |
| N02BA01 | acetylsalicylic acid |
| N02BA75 | salicylamide, combinations with psycholeptics |
| N02BB04 | propyphenazone |
| N02BE05 | propacetamol |
| N02BE51 | paracetamol, combinations excl. psycholeptics |
| N02BE54 | bucetin, combinations excl. psycholeptics |
| N02CA02 | ergotamine |
| N03AG06 | tiagabine |
| N03AX14 | levetiracetam |
| N03AX16 | pregabalin |
| N04AA01 | trihexyphenidyl |
| N04BC05 | pramipexole |
| N04BC09 | rotigotine |
| N04BX04 | opicapone |
| N05AB02 | fluphenazine |
| N05AB06 | trifluoperazine |
| N05AD08 | droperidol |
| N05AH04 | quetiapine |
| N05AL01 | sulpiride |
| N05BA02 | chlordiazepoxide |
| N05BA05 | potassium clorazepate |
| N05BB01 | hydroxyzine |
| N05BC01 | meprobamate |
| N05BD01 | benzoctamine |
| N05BE01 | buspirone |
| N05CA19 | thiopental |
| N05CD | Benzodiazepine derivatives |
| N05CD08 | midazolam |
| N05CM | Other hypnotics and sedatives |
| N06AA10 | nortriptyline |
| N06AA14 | melitracen |
| N06AX12 | bupropion |
| N06AX21 | duloxetine |
| N06BC01 | caffeine |
| N06BX06 | citicoline |
| N06DA02 | donepezil |
| N06DX01 | memantine |
| N07CA | Antivertigo preparations |
| N07CA01 | betahistine |
| N07XX02 | riluzole |
| P01CX01 | pentamidine isethionate |
| P02BA01 | praziquantel |
| P02CX01 | pyrvinium |
| R01AA04 | phenylephrine |
| R01AA09 | tramazoline |
| R01AB05 | ephedrine |
| R01AC01 | cromoglicic acid |
| R01AD03 | dexamethasone |
| R01AD07 | tixocortol |
| R01AX03 | ipratropium bromide |
| R02AA | Antiseptics |
| R03AK08 | formoterol and beclometasone |
| R03AK12 | salmeterol and budesonide |
| R03BA04 | betamethasone |
| R03BA07 | mometasone |
| R03BB05 | aclidinium bromide |
| R03CC07 | pirbuterol |
| R03DA04 | theophylline |
| R03DC53 | montelukast, combinations |
| J01ED | Long-acting sulfonamides |
| J01ED03 | sulfametomidine |
| J01ED07 | sulfamerazine |
| J01EE03 | sulfametrole and trimethoprim |
| J01FA01 | erythromycin |
| J01FA05 | oleandomycin |
| J01FF01 | clindamycin |
| J01MA09 | sparfloxacin |
| J01XA01 | vancomycin |
| J01XB02 | polymyxin B |
| J01XX10 | bacitracin |
| J02AB02 | ketoconazole |
| J02AC05 | isavuconazole |
| J02AX01 | flucytosine |
| J02AX04 | caspofungin |
| J04AB01 | cycloserine |
| J04AB05 | rifapentine |
| J04AM06 | rifampicin, pyrazinamide, ethambutol and isoniazid |
| J05AB09 | famciclovir |
| J05AB11 | valaciclovir |
| J05AE02 | indinavir |
| J05AE04 | nelfinavir |
| J05AF01 | zidovudine |
| J05AF11 | telbivudine |
| J05AG04 | etravirine |
| J05AG05 | rilpivirine |
| J05AH01 | zanamivir |
| J05AH03 | peramivir |
| J05AR02 | lamivudine and abacavir |
| J05AR03 | tenofovir disoproxil and emtricitabine |
| J05AR04 | zidovudine, lamivudine and abacavir |
| J05AR05 | zidovudine, lamivudine and nevirapine |
| J05AR06 | emtricitabine, tenofovir disoproxil and efavirenz |
| J05AR18 | emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat |
| J07AG | Haemophilus influenzae B vaccines |
| J07AL | Pneumococcal vaccines |
| J07AX | Other bacterial vaccines |
| J07BD54 | measles, combinations with mumps, rubella and varicella, live attenuated |
| J07BJ01 | rubella, live attenuated |
| L01AA03 | melphalan |
| L01AB01 | busulfan |
| L01BA03 | raltitrexed |
| L01BC03 | tegafur |
| L01BC05 | gemcitabine |
| L01CA03 | vindesine |
| L01DA01 | dactinomycin |
| L01DB01 | doxorubicin |
| L01DC03 | mitomycin |
| L01ED01 | crizotinib |
| L01EE01 | trametinib |
| L01EJ02 | fedratinib |
| L01EK01 | axitinib |
| L01EX12 | larotrectinib |
| L01EX16 | erdafitinib |
| L01XB01 | procarbazine |
| L01XC02 | rituximab |
| L01XC10 | ofatumumab |
| L01XC38 | isatuximab |
| L03AB09 | interferon alfacon-1 |
| L03AC01 | aldesleukin |
| L03AX03 | BCG vaccine |
| L04AA45 | filgotinib |
| L04AB06 | golimumab |
| L04AC07 | tocilizumab |
| L04AC11 | siltuximab |
| L04AC19 | satralizumab |
| L04AX02 | thalidomide |
| M01AB17 | bufexamac |
| M01AE07 | suprofen |
| M01AE11 | tiaprofenic acid |
| M01AE56 | naproxen and misoprostol |
| M01AX | Other antiinflammatory and antirheumatic agents, non-steroids |
| M01AX05 | glucosamine |
| M01AX17 | nimesulide |
| M01AX25 | chondroitin sulfate |
| M01CC01 | penicillamine |
| M02AA | Antiinflammatory preparations, non-steroids for topical use |
| M02AA06 | etofenamate |
| M02AA13 | ibuprofen |
| M02AA23 | indometacin |
| M03BB52 | chlormezanone, combinations excl. psycholeptics |
| M04A | ANTIGOUT PREPARATIONS |
| M05BB05 | alendronic acid, calcium and colecalciferol, sequential |
| M05BX06 | romosozumab |
| N01AF | Barbiturates, plain |
| N01BB02 | lidocaine |
| N01BB04 | prilocaine |
| N01BB20 | combinations |
| N01BB52 | lidocaine, combinations |
| N01BX03 | phenol |
| N01BX04 | capsaicin |
| N02AA | Natural opium alkaloids |
| N02B | OTHER ANALGESICS AND ANTIPYRETICS |
| N02BB52 | metamizole sodium, combinations excl. psycholeptics |
| N02BE74 | bucetin, combinations with psycholeptics |
| N02CD02 | galcanezumab |
| N02CX | Other antimigraine preparations |
| N03AA03 | primidone |
| N03AX24 | cannabidiol |
| N04BC03 | dihydroergocryptine mesylate |
| N04BC04 | ropinirole |
| N04BC07 | apomorphine |
| N04BD02 | rasagiline |
| N04BX02 | entacapone |
| N05AB | Phenothiazines with piperazine structure |
| R03AL07 | formoterol and glycopyrronium bromide |
| R03BA08 | ciclesonide |
| R03BB07 | umeclidinium bromide |
| R03CC05 | hexoprenaline |
| R03DA03 | proxyphylline |
| R03DC03 | montelukast |
| R03DX09 | mepolizumab |
| R05DA07 | noscapine |
| R05DA09 | dextromethorphan |
| R05DA20 | combinations |
| R05DB20 | combinations |
| R05FB | Other cough suppressants and expectorants |
| R05FB01 | cough suppressants and mucolytics |
| R06AA | Aminoalkyl ethers |
| R06AA02 | diphenhydramine |
| R06AA09 | doxylamine |
| R06AE05 | meclozine |
| R06AE55 | meclozine, combinations |
| R06AX02 | cyproheptadine |
| R06AX04 | phenindamine |
| R07AX | Other respiratory system products |
| S01AA05 | tyrothricin |
| S01AA20 | antibiotics in combination with other drugs |
| S01AA21 | amikacin |
| S01AE01 | ofloxacin |
| S01AE07 | moxifloxacin |
| S01BC03 | diclofenac |
| S01CB04 | betamethasone |
| S01EA04 | clonidine |
| S01EA05 | brimonidine |
| S01ED55 | carteolol, combinations |
| S01EE03 | bimatoprost |
| S01FA01 | atropine |
| S01KA02 | hypromellose |
| S01L | OCULAR VASCULAR DISORDER AGENTS |
| S01LA04 | ranibizumab |
| S01XA06 | ethylmorphine |
| S01XA13 | alteplase |
| S01XA14 | heparin |
| S01XA25 | lifitegrast |
| S02AA01 | chloramphenicol |
| S02AA03 | boric acid |
| S02AA11 | polymyxin B |
| S02CA06 | dexamethasone and antiinfectives |
| S03AA01 | neomycin |
| S03CA02 | prednisolone and antiinfectives |
| V01AA09 | textiles |
| V01AA11 | animals |
| V03 | ALL OTHER THERAPEUTIC PRODUCTS |
| V03AB25 | flumazenil |
| V03AB33 | hydroxocobalamin |
| V03AE | Drugs for treatment of hyperkalemia and hyperphosphatemia |
| V03AE02 | sevelamer |
| V04CC02 | magnesium sulfate |
| V06DD | Amino acids, incl. combinations with polypeptides |
| V06DE | Amino acids/carbohydrates/minerals/vitamins, combinations |
| V07A | ALL OTHER NON-THERAPEUTIC PRODUCTS |
| V08AA05 | ioxitalamic acid |
| V08AB06 | iotrolan |
| V08CA02 | gadoteric acid |
| V08CA05 | mangafodipir |
| V08CA10 | gadoxetic acid |
| V08CB03 | iron oxide, nanoparticles |
| V08DA01 | perflutren, human albumin microspheres |
| V09BA02 | technetium (99mTc) medronic acid |
| V09EX03 | xenon (133Xe) gas |
| V09FX01 | technetium (99mTc) pertechnetate |
| V09GA | Technetium (99mTc) compounds |
| V09IB01 | indium (111In) pentetreotide |
| V09XX | Various diagnostic radiopharmaceuticals |
| V10XX03 | radium (223Ra) dichloride |
| G03AA17 | medroxyprogesterone and estradiol |
| G03AB | Progestogens and estrogens, sequential preparations |
| G03CA01 | ethinylestradiol |
| G03DA | Pregnen (4) derivatives |
| G03DB03 | medrogestone |
| G03FA04 | progesterone and estrogen |
| G03FB09 | levonorgestrel and estrogen |
| G03GA07 | lutropin alfa |
| G03GA10 | follitropin delta |
| G03GB02 | clomifene |
| G04BX06 | phenazopyridine |
| G04CA02 | tamsulosin |
| G04CA03 | terazosin |
| G04CA53 | tamsulosin and solifenacin |
| H01CA02 | nafarelin |
| H01CC02 | cetrorelix |
| H02AB02 | dexamethasone |
| H02BX | Corticosteroids for systemic use, combinations |
| H02BX01 | methylprednisolone, combinations |
| H05BX01 | cinacalcet |
| H05BX03 | doxercalciferol |
| J01AA04 | lymecycline |
| J01CA13 | ticarcillin |
| J01CE02 | phenoxymethylpenicillin |
| J01CE08 | benzathine benzylpenicillin |
| J01CR | Combinations of penicillins, incl. beta-lactamase inhibitors |
| J01CR50 | combinations of penicillins |
| J01DB07 | cefatrizine |
| J01DC14 | flomoxef |
| J01DH | Carbapenems |
| J01EE06 | sulfadiazine and tetroxoprim |
| J01FA | Macrolides |
| J01FA15 | telithromycin |
| J01GB07 | netilmicin |
| J01GB08 | sisomicin |
| J01MA01 | ofloxacin |
| J01MA07 | lomefloxacin |
| J01RA04 | spiramycin and metronidazole |
| J01XD01 | metronidazole |
| J01XD03 | ornidazole |
| J01XE01 | nitrofurantoin |
| J02AC | Triazole and tetrazole derivatives |
| J02AC02 | itraconazole |
| J02AC03 | voriconazole |
| J02AX06 | anidulafungin |
| J04AB04 | rifabutin |
| J04AC51 | isoniazid, combinations |
| J04AD01 | protionamide |
| J04AD02 | tiocarlide |
| J05AB01 | aciclovir |
| J05AB06 | ganciclovir |
| J05AE01 | saquinavir |
| J05AF05 | lamivudine |
| J05AF08 | adefovir dipivoxil |
| J05AF13 | tenofovir alafenamide |
| J05AG01 | nevirapine |
| J05AH02 | oseltamivir |
| J05AP57 | glecaprevir and pibrentasvir |
| J05AR10 | lopinavir and ritonavir |
| J05AR13 | lamivudine, abacavir and dolutegravir |
| J05AR19 | emtricitabine, tenofovir alafenamide and rilpivirine |
| J05AR24 | lamivudine, tenofovir disoproxil and doravirine |
| J05AX07 | enfuvirtide |
| J05AX18 | letermovir |
| J06AA03 | snake venom antiserum |
| J07 | VACCINES |
| J07AH02 | other meningococcal monovalent purified polysaccharides antigen |
| J07AH09 | meningococcus B, multicomponent vaccine |
| J07AJ02 | pertussis, purified antigen |
| J07BC01 | hepatitis B, purified antigen |
| J07BE01 | mumps, live attenuated |
| J07BG01 | rabies, inactivated, whole virus |
| J07BM | Papillomavirus vaccines |
| J07BM03 | papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) |
| L01AA06 | ifosfamide |
| L01BA05 | pralatrexate |
| L01BB04 | cladribine |
| L01BC02 | fluorouracil |
| L01CA04 | vinorelbine |
| L01CD02 | docetaxel |
| L01DC04 | ixabepilone |
| L01EA02 | dasatinib |
| L01EB07 | dacomitinib |
| L01EG02 | everolimus |
| L01EX05 | regorafenib |
| L01EX07 | cabozantinib |
| L01EX17 | capmatinib |
| L01EX21 | tepotinib |
| L01XA02 | carboplatin |
| L01XD04 | aminolevulinic acid |
| L01XK01 | olaparib |
| L01XX11 | estramustine |
| L01XX35 | anagrelide |
| L02AA01 | diethylstilbestrol |
| L02BB04 | enzalutamide |
| L03AB04 | interferon alfa-2a |
| L03AB07 | interferon beta-1a |
| L04AA10 | sirolimus |
| L04AA18 | everolimus |
| M01AA03 | oxyphenbutazone |
| M01AE05 | fenbufen |
| M01AE09 | flurbiprofen |
| M01AE52 | naproxen and esomeprazole |
| M02AA17 | niflumic acid |
| M02AA18 | meclofenamic acid |
| N05CM01 | methaqualone |
| N05CM05 | scopolamine |
| N06AA04 | clomipramine |
| N06AB10 | escitalopram |
| N06AX11 | mirtazapine |
| N06BX02 | pyritinol |
| N06DX | Other anti-dementia drugs |
| P01AB51 | metronidazole and furazolidone |
| P01CC02 | nitrofural |
| P03AA03 | mesulfen |
| P03AC52 | bioallethrin, combinations |
| R01A | DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE |
| R01AA02 | cyclopentamine |
| R01AA14 | epinephrine |
| R01AD09 | mometasone |
| R01AD52 | prednisolone, combinations |
| R02AA05 | chlorhexidine |
| R02AA20 | various |
| R02AD01 | benzocaine |
| R02AX | Other throat preparations |
| R03A | ADRENERGICS, INHALANTS |
| R03AB03 | orciprenaline |
| R03AC02 | salbutamol |
| R03AC18 | indacaterol |
| R03AK10 | vilanterol and fluticasone furoate |
| R03AK11 | formoterol and fluticasone |
| R03BA05 | fluticasone |
| R03BX01 | fenspiride |
| R03CB | Non-selective beta-adrenoreceptor agonists |
| R03CB53 | orciprenaline, combinations |
| R03CC02 | salbutamol |
| R03CC13 | clenbuterol |
| R03DA05 | aminophylline |
| R03DA51 | diprophylline, combinations |
| R03DX05 | omalizumab |
| R05CA03 | guaifenesin |
| R05CB | Mucolytics |
| R05DB02 | benproperine |
| R05F | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
| R06AA52 | diphenhydramine, combinations |
| R06AD01 | alimemazine |
| R06AE | Piperazine derivatives |
| S01AA17 | erythromycin |
| S01AA26 | azithromycin |
| S01AX | Other antiinfectives |
| S01B | ANTIINFLAMMATORY AGENTS |
| S01BB01 | hydrocortisone and mydriatics |
| S01BC04 | flurbiprofen |
| S01BC06 | piroxicam |
| S01CA | Corticosteroids and antiinfectives in combination |
| S01CB01 | dexamethasone |
| S01CB03 | hydrocortisone |
| S01ED01 | timolol |
| S01EE05 | tafluprost |
| S01FA56 | tropicamide, combinations |
| S01GA04 | oxymetazoline |
| S01GA05 | phenylephrine |
| S01HA | Local anesthetics |
| S01HA07 | lidocaine |
| S01XA | Other ophthalmologicals |
| S01XA18 | ciclosporin |
| S02CA05 | fluocinolone acetonide and antiinfectives |
| S03BA01 | dexamethasone |
| V03AB | Antidotes |
| V03AB05 | prednisolone and promethazine |
| V03AC02 | deferiprone |
| V03AE03 | lanthanum carbonate |
| V03AX | Other therapeutic products |
| V04CA01 | tolbutamide |
| V04CF01 | tuberculin |
| V04CJ02 | protirelin |
| V06DX | Other combinations of nutrients |
| V08AB07 | ioversol |
| V08AB11 | iobitridol |
| V08CA09 | gadobutrol |
| V09 | DIAGNOSTIC RADIOPHARMACEUTICALS |
| V09AA01 | technetium (99mTc) exametazime |
| V09AA02 | technetium (99mTc) bicisate |
| V09FX | Various thyroid diagnostic radiopharmaceuticals |
| V09XX01 | cobalt (57Co) cyanocobalamine |
| V10XA | Iodine (131I) compounds |
| N05AB04 | prochlorperazine |
| N05AF02 | clopenthixol |
| N05AG02 | pimozide |
| N05AN01 | lithium |
| N05BA08 | bromazepam |
| N05CA10 | cyclobarbital |
| N05CD09 | brotizolam |
| N05CD15 | nimetazepam |
| N05CF04 | eszopiclone |
| N06AA09 | amitriptyline |
| N06AG02 | moclobemide |
| N06AX01 | oxitriptan |
| N06AX05 | trazodone |
| N06AX18 | reboxetine |
| N06BA09 | atomoxetine |
| N06BX03 | piracetam |
| N06CA01 | amitriptyline and psycholeptics |
| N06DA01 | tacrine |
| N07BC02 | methadone |
| P01AB02 | tinidazole |
| P01AR | Arsenic compounds |
| P01BA02 | hydroxychloroquine |
| P01BC01 | quinine |
| P01CB01 | meglumine antimonate |
| R01AA08 | naphazoline |
| R01AB01 | phenylephrine |
| R01AD02 | prednisolone |
| R01BA03 | phenylephrine |
| R02AA06 | cetylpyridinium |
| R02AX01 | flurbiprofen |
| R03AC06 | hexoprenaline |
| R03AK04 | salbutamol and sodium cromoglicate |
| R03AL01 | fenoterol and ipratropium bromide |
| R03AL04 | indacaterol and glycopyrronium bromide |
| R03BA06 | triamcinolone |
| R03BB01 | ipratropium bromide |
| R03CC09 | tretoquinol |
| R03CK | Adrenergics and other drugs for obstructive airway diseases |
| R03DA | Xanthines |
| R03DA01 | diprophylline |
| R03DA02 | choline theophyllinate |
| R03DA20 | combinations of xanthines |
| R03DB01 | diprophylline and adrenergics |
| R05DA04 | codeine |
| R05DB01 | benzonatate |
| R05DB04 | isoaminile |
| R05DB05 | pentoxyverine |
| R05FA01 | opium derivatives and mucolytics |
| R06AA06 | chlorphenoxamine |
| R06AB02 | dexchlorpheniramine |
| R06AD02 | promethazine |
| R06AD07 | mequitazine |
| R06AE03 | cyclizine |
| R06AE07 | cetirizine |
| R06AX13 | loratadine |
| R06AX17 | ketotifen |
| R06AX29 | bilastine |
| R07AB01 | doxapram |
| S01AA09 | tetracycline |
| S01AA12 | tobramycin |
| S01AD01 | idoxuridine |
| S01AE02 | norfloxacin |
| S01BA02 | hydrocortisone |
| S01BA13 | rimexolone |
| S01BC | Antiinflammatory agents, non-steroids |
| S01BC01 | indometacin |
| S01BC08 | salicylic acid |
| S01C | ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION |
| S01CA01 | dexamethasone and antiinfectives |
| S01E | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| S01EA01 | epinephrine |
| S01EA51 | epinephrine, combinations |
| S01EB06 | neostigmine |
| S01ED02 | betaxolol |
| S01GA01 | naphazoline |
| S01GA07 | brimonidine |
| S01GA53 | xylometazoline, combinations |
| S01GX | Other antiallergics |
| S01GX08 | ketotifen |
| S01GX09 | olopatadine |
| S01HA06 | cinchocaine |
| S01XA02 | retinol |
| S01XA05 | sodium edetate |
| S02BA07 | betamethasone |
| S02CA04 | triamcinolone and antiinfectives |
| S02DA | Analgesics and anesthetics |
| S03AA02 | tetracycline |
| S03AA03 | polymyxin B |
| S03AA04 | chlorhexidine |
| V03AE08 | ferric citrate |
| V03AF04 | calcium levofolinate |
| V03AF05 | amifostine |
| V03AN01 | oxygen |
| V04CD03 | sermorelin |
| V04CM01 | gonadorelin |
| V04CX | Other diagnostic agents |
| V04CX01 | indocyanine green |
| V07AB | Solvents and diluting agents, incl. irrigating solutions |
| V08AB02 | iohexol |
| V08CA08 | gadobenic acid |
| V08CX | Other magnetic resonance imaging contrast media |
| R03DX | Other systemic drugs for obstructive airway diseases |
| R05CA02 | potassium iodide |
| R05DB | Other cough suppressants |
| R05DB09 | oxeladin |
| R05DB21 | cloperastine |
| R06AB54 | chlorphenamine, combinations |
| R06AC04 | tripelennamine |
| R06AX25 | mizolastine |
| S01AA | Antibiotics |
| S01AA01 | chloramphenicol |
| S01AA04 | oxytetracycline |
| S01AA10 | natamycin |
| S01AA11 | gentamicin |
| S01AA14 | benzylpenicillin |
| S01AB01 | sulfamethizole |
| S01AD03 | aciclovir |
| S01AE03 | ciprofloxacin |
| S01AX09 | chlorhexidine |
| S01BA01 | dexamethasone |
| S01EB01 | pilocarpine |
| S01EC01 | acetazolamide |
| S01EE01 | latanoprost |
| S01EX | Other antiglaucoma preparations |
| S01FA05 | homatropine |
| S01GA | Sympathomimetics used as decongestants |
| S01HA03 | tetracaine |
| S01XA03 | sodium chloride, hypertonic |
| S01XA04 | potassium iodide |
| S02AA | Antiinfectives |
| S02AA05 | clioquinol |
| S02BA | Corticosteroids |
| S02BA03 | prednisolone |
| S02BA08 | fluocinolone acetonide |
| S02DA01 | lidocaine |
| S03AA07 | ciprofloxacin |
| V03AB03 | edetates |
| V03AE07 | calcium acetate |
| V03AF01 | mesna |
| V03AF03 | calcium folinate |
| V04CL | Tests for allergic diseases |
| V04CX02 | folic acid |
| V06 | GENERAL NUTRIENTS |
| V06DC | Carbohydrates |
| V07 | ALL OTHER NON-THERAPEUTIC PRODUCTS |
| V08 | CONTRAST MEDIA |
| V08A | X-RAY CONTRAST MEDIA, IODINATED |
| V08AA01 | diatrizoic acid |
| V08AB04 | iopamidol |
| V08AB05 | iopromide |
| V08BA | Barium sulfate containing X-ray contrast media |
| V08CA03 | gadodiamide |
| V09A | CENTRAL NERVOUS SYSTEM |
| V09BA03 | technetium (99mTc) pyrophosphate |
| V09CA | Technetium (99mTc) compounds |
| V09CX02 | sodium iodohippurate (131I) |
| V09GA04 | technetium (99mTc) human albumin |
| V09IX06 | sodium fluoride (18F) |
| M02AA19 | flurbiprofen |
| M03AC01 | pancuronium |
| M03AC03 | vecuronium |
| M03AC04 | atracurium |
| M03B | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
| M03BX04 | tolperisone |
| M04AA03 | febuxostat |
| M04AB03 | benzbromarone |
| M04AC01 | colchicine |
| M05BB08 | zoledronic acid, calcium and colecalciferol, sequential |
| M05BX04 | denosumab |
| N01AF03 | thiopental |
| N01AH03 | sufentanil |
| N01AH51 | fentanyl, combinations |
| N01AX07 | etomidate |
| N01AX10 | propofol |
| N01BA02 | procaine |
| N01BA05 | benzocaine |
| N01BA52 | procaine, combinations |
| N01BB | Amides |
| N01BB54 | prilocaine, combinations |
| N02AA55 | oxycodone and naloxone |
| N02AA56 | oxycodone and naltrexone |
| N02AA79 | codeine, combinations with psycholeptics |
| N02AF | Morphinan derivatives |
| N02AJ15 | tramadol and other non-opioid analgesics |
| N02BA07 | ethenzamide |
| N02BB | Pyrazolones |
| N02BB74 | propyphenazone, combinations with psycholeptics |
| N02BG | Other analgesics and antipyretics |
| N02BG11 | mirogabalin |
| N02CX05 | dimetotiazine |
| N03AA02 | phenobarbital |
| N03AB52 | phenytoin, combinations |
| N04BC01 | bromocriptine |
| N04BC06 | cabergoline |
| N05BA17 | fludiazepam |
| N05CA06 | secobarbital |
| N05CD01 | flurazepam |
| N05CM03 | bromisoval |
| N05CM12 | apronal |
| N06AA12 | doxepin |
| N06AA21 | maprotiline |
| N06AB08 | fluvoxamine |
| N06AX03 | mianserin |
| N06DX02 | Ginkgo folium |
| N07AA51 | neostigmine, combinations |
| N07AX03 | cevimeline |
| N07BB03 | acamprosate |
| N07CA03 | flunarizine |
| P01AB06 | nimorazole |
| P01AX02 | emetine |
| P01BC02 | mefloquine |
| P02 | ANTHELMINTICS |
| P02CC01 | pyrantel |
| P02CE01 | levamisole |
| P02CF01 | ivermectin |
| P02CX | Other antinematodals |
| P03BX01 | diethyltoluamide |
| R01AA03 | ephedrine |
| R01AB | Sympathomimetics, combinations excl. corticosteroids |
| R01AC | Antiallergic agents, excl. corticosteroids |
| R01AC03 | azelastine |
| R01AC04 | antazoline |
| R01AD06 | betamethasone |
| R01AX06 | mupirocin |
| R01BA51 | phenylpropanolamine, combinations |
| R01BA52 | pseudoephedrine, combinations |
| R02AB01 | neomycin |
| R02AB03 | fusafungine |
| R02AB30 | gramicidin |
| R02AD03 | cocaine |
| R03AC | Selective beta-2-adrenoreceptor agonists |
| R03AC03 | terbutaline |
| R03AC09 | tretoquinol |
| R03CB02 | methoxyphenamine |
| R03CB03 | orciprenaline |
| R03CC | Selective beta-2-adrenoreceptor agonists |
| R03CC03 | terbutaline |
| R03CC08 | procaterol |
| R03DB | Xanthines and adrenergics |
| R03DB04 | theophylline and adrenergics |
| R03DX10 | benralizumab |
| R05CA06 | senega |
| R05CB01 | acetylcysteine |
| R05CB03 | carbocisteine |
| R05CB04 | eprazinone |
| R05CB05 | mesna |
| R05CB15 | erdosteine |
| R05CB16 | mannitol |
| R05DA11 | dimemorfan |
| R05DB07 | oxolamine |
| R05X | OTHER COLD PREPARATIONS |
| R06AA07 | diphenylpyraline |
| R06AB51 | brompheniramine, combinations |
| R06AB52 | dexchlorpheniramine, combinations |
| R06AD52 | promethazine, combinations |
| R06AE01 | buclizine |
| R06AE04 | chlorcyclizine |
| R06AE51 | buclizine, combinations |
| R06AX | Other antihistamines for systemic use |
| R06AX07 | triprolidine |
| R06AX09 | azatadine |
| R06AX11 | astemizole |
| S01AA13 | fusidic acid |
| S01AA18 | polymyxin B |
| S01AA24 | kanamycin |
| S01AE04 | lomefloxacin |
| S01AX07 | sodium borate |
| S01AX18 | povidone-iodine |
| S01BA06 | betamethasone |
| S01BA07 | fluorometholone |
| S01BB04 | betamethasone and mydriatics |
| J05AR11 | lamivudine, tenofovir disoproxil and efavirenz |
| J05AR20 | emtricitabine, tenofovir alafenamide and bictegravir |
| J05AR21 | dolutegravir and rilpivirine |
| J05AR27 | lamivudine, tenofovir disoproxil and dolutegravir |
| J06BB16 | palivizumab |
| J07AJ51 | pertussis, inactivated, whole cell, combinations with toxoids |
| J07BA02 | encephalitis, Japanese, inactivated, whole virus |
| J07BC02 | hepatitis A, inactivated, whole virus |
| J07BH02 | rota virus, pentavalent, live, reassorted |
| J07BK02 | zoster, live attenuated |
| L01AA01 | cyclophosphamide |
| L01BB02 | mercaptopurine |
| L01BC01 | cytarabine |
| L01CB02 | teniposide |
| L01CD04 | cabazitaxel |
| L01DB06 | idarubicin |
| L01EA01 | imatinib |
| L01EB04 | osimertinib |
| L01ED02 | ceritinib |
| L01EE02 | cobimetinib |
| L01EG01 | temsirolimus |
| L01EJ01 | ruxolitinib |
| L01EL01 | ibrutinib |
| L01XC08 | panitumumab |
| L01XF01 | tretinoin |
| L01XJ01 | vismodegib |
| L01XK02 | niraparib |
| L01XX02 | asparaginase |
| L02AA04 | fosfestrol |
| L02AE03 | goserelin |
| L02AE51 | leuprorelin and bicalutamide |
| L02BX02 | degarelix |
| L03AA03 | molgramostim |
| L03AB05 | interferon alfa-2b |
| L03AB11 | peginterferon alfa-2a |
| L03AB15 | ropeginterferon alfa-2b |
| L03AX13 | glatiramer acetate |
| L04AA02 | muromonab-CD3 |
| L04AA38 | ozanimod |
| L04AA43 | ravulizumab |
| L04AA47 | inebilizumab |
| L04AB02 | infliximab |
| L04AC01 | daclizumab |
| L04AC10 | secukinumab |
| L04AD02 | tacrolimus |
| L04AX01 | azathioprine |
| L04AX05 | pirfenidone |
| M01AB05 | diclofenac |
| M01AB15 | ketorolac |
| M01AE01 | ibuprofen |
| M01AE51 | ibuprofen, combinations |
| M01AG04 | meclofenamic acid |
| M01CB01 | sodium aurothiomalate |
| M02AA10 | ketoprofen |
| M02AA15 | diclofenac |
| M02AC | Preparations with salicylic acid derivatives |
| M03AA01 | alcuronium |
| M03AC09 | rocuronium bromide |
| M03BB03 | chlorzoxazone |
| M03BB53 | chlorzoxazone, combinations excl. psycholeptics |
| M03BC01 | orphenadrine (citrate) |
| M03BX | Other centrally acting agents |
| M03BX06 | mephenesin |
| M05BA08 | zoledronic acid |
| N01AB01 | halothane |
| N01AB07 | desflurane |
| N01BA01 | metabutethamine |
| N02AJ07 | codeine and acetylsalicylic acid |
| N02AJ08 | codeine and ibuprofen |
| N02AJ17 | oxycodone and paracetamol |
| N02AJ19 | oxycodone and ibuprofen |
| N02AX02 | tramadol |
| N02AX06 | tapentadol |
| N02BA | Salicylic acid and derivatives |
| N02BA55 | salicylamide, combinations excl. psycholeptics |
| N02BA57 | ethenzamide, combinations excl. psycholeptics |
| N02BB02 | metamizole sodium |
| N02BE04 | bucetin |
| N02CC02 | naratriptan |
| N02CC06 | eletriptan |
| N03AF03 | rufinamide |
| N03AG | Fatty acid derivatives |
| N03AX11 | topiramate |
| N03AX12 | gabapentin |
| N04AA02 | biperiden |
| N04AB02 | orphenadrine (chloride) |
| N04BA01 | levodopa |
| N05AF03 | chlorprothixene |
| N05AF04 | tiotixene |
| N05AH01 | loxapine |
| N05AH06 | clotiapine |
| N05AX08 | risperidone |
| N05BA04 | oxazepam |
| N05BA06 | lorazepam |
| N05BX01 | mephenoxalone |
| N05CA21 | allobarbital |
| N06AB03 | fluoxetine |
| N06AX22 | agomelatine |
| N06AX26 | vortioxetine |
| N06AX27 | esketamine |
| N07BC51 | buprenorphine, combinations |
| P01AX | Other agents against amoebiasis and other protozoal diseases |
| P01AX07 | trimetrexate |
| P03AX | Other ectoparasiticides, incl. scabicides |
| P03BX | Other insecticides and repellents |
| R01AD05 | budesonide |
| R01AD08 | fluticasone |
| S01CA02 | prednisolone and antiinfectives |
| S01CA07 | fluorometholone and antiinfectives |
| S01CB05 | fluorometholone |
| S01CC02 | indometacin and antiinfectives |
| S01EA02 | dipivefrine |
| S01EC03 | dorzolamide |
| S01EC04 | brinzolamide |
| S01ED04 | metipranolol |
| S01F | MYDRIATICS AND CYCLOPLEGICS |
| S01GX01 | cromoglicic acid |
| S01GX06 | emedastine |
| S01HA01 | cocaine |
| S01JA01 | fluorescein |
| S01KX01 | chymotrypsin |
| S01LA01 | verteporfin |
| S01LA06 | brolucizumab |
| S01XA11 | nandrolone |
| S01XA20 | artificial tears and other indifferent preparations |
| S02AA09 | chlorhexidine |
| S02AA30 | antiinfectives, combinations |
| S02CA | Corticosteroids and antiinfectives in combination |
| S03BA02 | prednisolone |
| S03BA03 | betamethasone |
| V01AA03 | house dust mites |
| V03A | ALL OTHER THERAPEUTIC PRODUCTS |
| V03AB14 | protamine |
| V03AB32 | glutathione |
| V03AB34 | fomepizole |
| V03AB35 | sugammadex |
| V03AC01 | deferoxamine |
| V03AN02 | carbon dioxide |
| V03AZ01 | ethanol |
| V04 | DIAGNOSTIC AGENTS |
| V04CA02 | glucose |
| V04CB01 | vitamin A concentrates |
| V04CJ01 | thyrotropin |
| V04CX03 | methacholine |
| V06B | PROTEIN SUPPLEMENTS |
| V06DC01 | glucose |
| V07AC | Blood transfusion, auxiliary products |
| V07AX | Washing agents etc. |
| V07AY | Other non-therapeutic auxiliary products |
| V08AB09 | iodixanol |
| V08BA01 | barium sulfate with suspending agents |
| V08CA01 | gadopentetic acid |
| V09CA01 | technetium (99mTc) pentetic acid |
| V09GX | Other cardiovascular system diagnostic radiopharmaceuticals |
| V09IX04 | fludeoxyglucose (18F) |
| V09XX02 | cobalt (58Co) cyanocobalamine |
| V10XX04 | lutetium (177Lu) oxodotreotide |
| R01AD11 | triamcinolone |
| R01AD58 | fluticasone, combinations |
| R01AD59 | mometasone, combinations |
| R01BA53 | phenylephrine, combinations |
| R02A | THROAT PREPARATIONS |
| R02AA15 | povidone-iodine |
| R02AA19 | phenol |
| R02AB04 | bacitracin |
| R03AA01 | epinephrine |
| R03AK07 | formoterol and budesonide |
| R03AK09 | formoterol and mometasone |
| R03AK14 | indacaterol and mometasone |
| R03AL06 | olodaterol and tiotropium bromide |
| R03AL08 | vilanterol, umeclidinium bromide and fluticasone furoate |
| R03BB06 | glycopyrronium bromide |
| R03BC01 | cromoglicic acid |
| R03CA | Alpha- and beta-adrenoreceptor agonists |
| R03CC12 | bambuterol |
| R03DA54 | theophylline, combinations excl. psycholeptics |
| R03DA74 | theophylline, combinations with psycholeptics |
| R03DC01 | zafirlukast |
| R03DX07 | roflumilast |
| R05CA07 | antimony pentasulfide |
| R05CA09 | guaiacolsulfonate |
| R05CB02 | bromhexine |
| R05CB06 | ambroxol |
| R05CB10 | combinations |
| R05DB13 | butamirate |
| R05FA | Opium derivatives and expectorants |
| R05FB02 | cough suppressants and expectorants |
| R06AA04 | clemastine |
| R06AB01 | brompheniramine |
| R06AB04 | chlorphenamine |
| R06AB05 | pheniramine |
| R06AE09 | levocetirizine |
| R06AK | Combinations of antihistamines |
| R06AX15 | mebhydrolin |
| R06AX22 | ebastine |
| R06AX58 | pyrrobutamine, combinations |
| R07AA01 | colfosceril palmitate |
| S01A | ANTIINFECTIVES |
| S01AA02 | chlortetracycline |
| S01AA03 | neomycin |
| S01BA14 | loteprednol |
| S01ED03 | levobunolol |
| S01EE06 | latanoprostene bunod |
| S01FA03 | methylscopolamine |
| S01FB01 | phenylephrine |
| S01GA52 | tetryzoline, combinations |
| S01GA55 | phenylephrine, combinations |
| S01HA02 | oxybuprocaine |
| S01HA04 | proxymetacaine |
| S01XA12 | dexpanthenol |
| S02AA02 | nitrofural |
| S02AA14 | gentamicin |
| S02AA15 | ciprofloxacin |
| S02BA06 | dexamethasone |
| S02DA04 | cinchocaine |
| S03AA06 | gentamicin |
| S03CA04 | hydrocortisone and antiinfectives |
| S03CA06 | betamethasone and antiinfectives |
| V01AA | Allergen extracts |
| V01AA02 | grass pollen |
| V01AA05 | tree pollen |
| V03AB15 | naloxone |
| V03AB16 | ethanol |
| V03AC03 | deferasirox |
| V03AE04 | calcium acetate and magnesium carbonate |
| V03AF07 | rasburicase |
| V04CC01 | sorbitol |
| V04CX05 | 13C-urea |
| V06D | OTHER NUTRIENTS |
| V08AB | Watersoluble, nephrotropic, low osmolar X-ray contrast media |
| V08AD01 | ethyl esters of iodised fatty acids |
| V08CA06 | gadoversetamide |
| V08DA06 | perflubutane, phospholipid microspheres |
| V09BA | Technetium (99mTc) compounds |
| V09DB07 | technetium (99mTc) phytate |
| V09FX03 | sodium iodide (131I) |
| V09GX01 | thallium (201Tl) chloride |
| V09IA | Technetium (99mTc) compounds |
| V09IB | Indium (111In) compounds |
| V09IX12 | fluciclovine (18F) |
| V09XA | Iodine (131I) compounds |
| N07AA02 | pyridostigmine |
| N07XX08 | tafamidis |
| P01AB03 | ornidazole |
| P02CA01 | mebendazole |
| P03AC02 | bioallethrin |
| P03AX01 | benzyl benzoate |
| P03AX05 | dimeticone |
| R01AA06 | tetryzoline |
| R01AB02 | naphazoline |
| R01AD60 | hydrocortisone, combinations |
| R01BA01 | phenylpropanolamine |
| R02AD02 | lidocaine |
| R03AC13 | formoterol |
| R03AC19 | olodaterol |
| R03AK06 | salmeterol and fluticasone |
| R03AK13 | salbutamol and beclometasone |
| R03AL02 | salbutamol and ipratropium bromide |
| R03BA01 | beclometasone |
| R03BA02 | budesonide |
| R03BA09 | fluticasone furoate |
| R03BB04 | tiotropium bromide |
| R03CA02 | ephedrine |
| R03CB01 | isoprenaline |
| R03CC04 | fenoterol |
| R05CA04 | ipecacuanha |
| R05DA01 | ethylmorphine |
| R05DB10 | clofedanol |
| R05DB16 | dibunate |
| R05DB24 | tipepidine |
| R05FA02 | opium derivatives and expectorants |
| R06AA08 | carbinoxamine |
| R06AA59 | doxylamine, combinations |
| R06AC01 | mepyramine |
| R06AE06 | oxatomide |
| R07AA02 | natural phospholipids |
| R07AB05 | bemegride |
| S01AA23 | netilmicin |
| S01AB | Sulfonamides |
| S01AE05 | levofloxacin |
| S01AX03 | zinc compounds |
| S01BA05 | triamcinolone |
| S01BC05 | ketorolac |
| S01BC10 | nepafenac |
| S01CA03 | hydrocortisone and antiinfectives |
| S01CA08 | methylprednisolone and antiinfectives |
| S01EC54 | brinzolamide, combinations |
| S01ED05 | carteolol |
| S01ED54 | metipranolol, combinations |
| S01EE04 | travoprost |
| S01FA04 | cyclopentolate |
| S01FA06 | tropicamide |
| S01FB02 | ephedrine |
| S01GA02 | tetryzoline |
| S01GA51 | naphazoline, combinations |
| S01LA03 | pegaptanib |
| S01X | OTHER OPHTHALMOLOGICALS |
| S01XA10 | inosine |
| S01XA22 | ocriplasmin |
| S02AA08 | tetracycline |
| S02AA13 | miconazole |
| S02AA16 | ofloxacin |
| S02BA01 | hydrocortisone |
| S02CA01 | prednisolone and antiinfectives |
| S02DA02 | cocaine |
| S02DC | Indifferent preparations |
| V01AA08 | food |
| V03AB06 | thiosulfate |
| V03AB23 | acetylcysteine |
| V04CG30 | caffeine and sodium benzoate |
| V08AA04 | iotalamic acid |
| V08BA02 | barium sulfate without suspending agents |
| V08DA05 | sulfur hexafluoride, phospholipid microspheres |
| V09AA | Technetium (99mTc) compounds |
| V09G | CARDIOVASCULAR SYSTEM |
| V09GX03 | chromium (51Cr) chromate labelled cells |
| V09HX01 | gallium (67Ga) citrate |
| V09IX | Other diagnostic radiopharmaceuticals for tumour detection |
| V10AA | Yttrium (90Y) compounds |
| V10XA01 | sodium iodide (131I) |
Generated Narrative: ValueSet
Expansion based on codesystem WHO ATC version2020-05
This value set contains 1,000 concepts
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |